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Obesity results from an excess of adipose tissue and is a major risk factor for type 2 
diabetes, cardiovascular disease, and cancer.  Adipose tissue exists in two main forms: 
white adipose tissue (WAT), which stores energy as triglycerides, and brown adipose 
tissue (BAT), which dissipates stored energy as heat.  White adipose tissue is composed of 
several subcutaneous and visceral depots, each possessing distinct molecular and 
functional characteristics.  Brown-like adipocytes can emerge in WAT depots in response 
to cold or beta-adrenergic stimulation.  These cells have been called “beige” or “brite” 
(brown-in-white) cells.  The reduction of obesity in mice treated with beta-adrenergic 
agonists is correlated with the emergence of beige cells.  Beige cell development occurs 
 xiii 
most readily in subcutaneous depots, and to the least extent in visceral depots.  
Understanding the molecular mechanisms underlying beige cell development in different 
WAT depots may be important in discovering new therapies against obesity and related 
diseases.   
Our lab has previously discovered that Tyrosine Kinase 2 (Tyk2), an important 
mediator of cytokine signaling, promotes the development of classical brown adipose 
tissue.  Due to the lack of functional BAT, Tyk2-knockout (Tyk2-/-) mice become grossly 
obese with age and develop several symptoms of the metabolic syndrome.  In the present 
study, we have found a potential role of Tyk2 in the development of beige cells.  Here, we 
show that mRNA expression of BAT-selective genes (UCP1, Cidea, Cox8b, and Elovl3) is 
significantly reduced in subcutaneous WAT of Tyk2-knockout (Tyk2-/-) mice compared to 
wild-type mice.  Surprisingly, BAT-selective genes are induced in Tyk2-/- subcutaneous 
WAT by acute starvation.  These findings suggest that Tyk2 is required for the 
development of beige cells under ambient conditions, and that the need for Tyk2 in beige 
cell development is bypassed during nutritional stress, a stimulus of the sympathetic 
response. 
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CHAPTER 1: INTRODUCTION 
 
1.1 The Obesity Epidemic 
 Over centuries, humans have evolved an enhanced ability to store energy as fat in 
order to survive periods of famine.  However, in modern societies where energy-dense 
foods are abundant and available, this ability no longer provides a survival advantage but 
instead drives unprecedented weight gain.  During the last 20 years, obesity has become a 
worldwide epidemic that continues to grow at an alarming rate.  In 2008, 1.5 billion adults 
age 20 and older were overweight, 700 million of them being obese (World Health 
Organization, 2010).  In 2010, 43 million children under the age of 5 were overweight 
(World Health Organization, 2010).  In the United States, obesity among adults has 
doubled since 1980, while the number of overweight adolescents has tripled (U.S. 
Department of Health and Human Services, 2001).   
The rising rates of obesity have increased the prevalence of chronic life-threatening 
diseases, including hypertension, dyslipidemia (high levels of total cholesterol and 
triglycerides), type 2 diabetes, coronary heart disease, stroke, gallbladder disease, 
osteoarthritis, sleep apnea, and some cancers (endometrial, breast, and colon) (National 
Heart, Lung, and Blood Institute, 1998).  Obesity is the fifth leading risk for global deaths, 
causing 2.8 million deaths each year (World Health Organization, 2010).  In the United 
States alone, obesity is responsible for about 300,000 deaths per year and is the second 
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leading cause of preventable deaths (U.S. Department of Health and Human Services, 
2001).  In addition to its health impacts, obesity has a significant impact on the economy.  
In 2008, overall medical costs for obesity-related diseases in the United States were $147 
billion, approximately 10% of national health care expenditures (Finkelstein et al., 2009).  
Furthermore, obesity is often associated with lost work productivity and chronic absence 
from work (Ferrie et al., 2007). 
 
1.2 Obesity 
 Obesity is a chronic metabolic disease that is characterized by excess body fat.  It 
develops when energy intake exceeds energy expenditure over time.  Obesity plays a 
significant role in the development of the metabolic syndrome.  The metabolic syndrome, 
also referred to as insulin resistance syndrome or syndrome X, is a constellation of 
metabolic risk factors that increase the risk for coronary artery disease, stroke, and type 2 
diabetes (Grundy, 2005).  These risk factors include abdominal obesity, dyslipidemia (high 
levels of triglycerides, low levels of high-density lipoprotein (HDL) cholesterol), 
hypertension, insulin resistance, a pro-thrombotic state (elevated levels of clotting factors), 
and a pro-inflammatory state (increased levels of pro-inflammatory cytokines) (Grundy, 
2005).    
Obesity can be diagnosed in several ways.  The most common measure of obesity 
is body mass index (BMI).  BMI is an indirect measure of total body fat and is calculated 
by dividing weight by height squared (kg/m
2
).  Individuals with a BMI over 25 kg/m
2
 are 
considered overweight, while individuals with a BMI over 30 kg/m
2
 are considered obese 
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(Centers for Disease Control and Prevention, 2010).  Other measures of overweight and 
obesity include: waist circumference, skinfold thickness, waist-to-hip circumference ratio, 
and more advanced techniques that directly measure body fat, such as ultrasound, 
computed tomography (CT), and magnetic resonance imaging (MRI) (Centers for Disease 
Control and Prevention, 2010).  In lean adults, body fat accounts for about 8-18% of body 
weight in men and 14-28% in women (Wilmore and Costill, 1988).  In obese adults, the 
amount of body fat can increase by fourfold to reach 60-70% of body weight. 
The cause of obesity cannot be explained by a single factor alone.  Genes, 
metabolism, behavior, and environment all contribute to the development of obesity 
(Centers for Disease Control and Prevention, 2010).  Family, twin, and adoption studies 
show that heredity is a strong predictor of obesity (Andersson and Walley, 2011).  
However, the rapid increase in the prevalence of obesity is most likely due to 
environmental factors, such as high-fat diets and/or decreased physical activity (Schmidt, 
2002).  Not only does environment cause obesity, it can also aggravate obesity in 
individuals genetically predisposed to the disease (Schmidt, 2002).  Nevertheless, obesity 
is a complex problem that results from an interplay between various factors.  The 
complexity of obesity presents a challenge in developing therapies for this disease and 
demonstrates a clear need to better understand its underlying mechanisms. 
 
1.3 Adipose Tissue  
 Adipose tissue plays a critical role in regulating the balance between energy intake 
and energy expenditure.  Two main types of adipose tissue exist: white adipose tissue and 
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brown adipose tissue.  White adipose tissue (WAT) stores energy in the form of 
triglycerides, which are then metabolized into a form that can be used when energy is 
needed.  WAT also functions as an endocrine organ, secreting adipokines—hormones, pro-
inflammatory cytokines, and other proteins produced by adipose tissue—that regulate 
overall metabolism.  In contrast to WAT, brown adipose tissue (BAT) oxidizes stored 
lipids to produce heat, a process called thermogenesis.  
 WAT and BAT differ widely in their morphology, reflecting their different 
functional roles.  White adipocytes consist of a single, large lipid droplet, minimal 
cytoplasm, and few small mitochondria with randomly oriented cristae.  Brown adipocytes 
are smaller, contain fewer lipids, which are stored in multilocular rather than unilocular 
droplets, and possess many large mitochondria densely packed with laminar cristae.  
Macroscopically, WAT is white to yellowish in color, and BAT is brownish-red due to its 
abundance of iron-containing mitochondria.  Compared to WAT, BAT is more highly 
vascularized with a dense network of capillaries, and more highly innervated by fibers of 
the sympathetic nervous system (SNS).  BAT has a high oxidative capacity due to 
enhanced expression of genes involved in fatty acid oxidation and mitochondrial 
respiration.  The most distinguishing feature of BAT is its unique expression of uncoupling 
protein 1 (UCP1), a 32-kDa protein found in the inner mitochondrial membrane (IMM).  
BAT thermogenesis is completely dependent on UCP1, which functions primarily in the 
uncoupling of mitochondrial respiration and ATP synthesis.  This uncoupling dissipates 
the proton gradient across the IMM that is generated by the electron transport chain, 
releasing chemical energy as heat. 
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Adipose tissue is located in several discrete areas of the body, which differ 
somewhat between mouse and human.  In rodents, BAT is found primarily between the 
shoulder blades (interscapular), in the neck (cervical), in the armpits (axillary), around the 
kidneys (retroperitoneal, or perirenal), and surrounding major arteries in the thoracic cavity 
(mediastinal, or para-aortic).  In humans, BAT is found in the neck, above the clavicle 
(supraclavicular), adjacent to the vertebrae (paravertebral), around the kidneys, and in the 
mediastinal and para-aortic regions.  In both mice and humans, WAT is found in the 
abdomen surrounding internal organs (visceral) and underneath the skin (subcutaneous).  
The main visceral depots are located adjacent to the stomach and spleen (omental), the 
intestines (mesenteric), kidneys, epidydimal tubes (epidydimal) or ovaries (periovarian, or 
parametrial), and the heart (cardiac).  Unlike mice, humans do not possess epidydimal 
WAT.  The subcutaneous depots are located primarily in the lower body, with minor 
amounts found in the upper body.  In mice, the lower subcutaneous depot surrounds the 
pelvis, from the back to the front of the hind legs (inguinal, or posterior), while the upper 
depots reside between the shoulder blades (interscapular, or anterior), in the armpits 
(axillary), and in the neck (cervical).  In humans, subcutaneous fat exists mainly in the 
buttocks, hips, and thighs.  The relative amount of each adipose depot is not fixed, but 
varies depending on several factors, including age, sex, environmental temperature, and 
nutritional status (Cinti, 2009).   
Despite the differences in anatomical location, human and murine adipose tissues 
are morphologically and functionally similar.  Based on gene expression, the inguinal 
depot in mice is considered the equivalent of subcutaneous WAT in humans, whereas the 
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epidydimal depot, referred to as the “purest” visceral WAT depot in mice, is considered the 
equivalent of visceral WAT in humans.  The features that characterize WAT and BAT are 
well described in a review by Fruhbeck et al. (2009) and are summarized in Table 1.1. 
 
 
Table 1: Characteristics of White and Brown Adipose Tissue (modified from 
Fruhbeck et al., 2009) 
 
 
1.4 White Adipose Tissue  
 White adipose tissue plays a multifaceted role in energy homeostasis.  WAT stores 
energy in the form of triglycerides during excess energy intake (i.e., feeding), releases 
energy as free fatty acids (FFAs) for other organs during energy need (i.e., fasting), and 
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secretes adipokines that communicate with other organs to regulate metabolism.  White 
adipose tissue is composed of several depots, categorized as visceral WAT or 
subcutaneous WAT.   
Although visceral and subcutaneous WAT are derived from the same origin, they 
are functionally different tissues.  Visceral WAT and subcutaneous WAT differ by their 
cellular and molecular composition, lipolytic activity, endocrine function, and response to 
insulin and other hormones (Ibrahim, 2010).  Differences in gene expression underlie these 
functional differences (Gesta et al., 2006).  Compared to subcutaneous WAT, visceral 
WAT is more cellular, containing more immune cells, inflammatory cells (macrophages), 
and large adipocytes.  Large adipocytes in visceral WAT are less efficient in absorbing and 
storing fatty acids than small adipocytes found in subcutaneous WAT (Marin et al., 1992).  
Visceral WAT is more vascularized than subcutaneous WAT, allowing for greater 
secretory activity of pro-inflammatory cytokines and growth factors, such as resistin, 
TNFalpha, IL-6, and CRP (Ibrahim, 2010; Manopolopoulos, 2010).  Subcutaneous WAT, 
on the other hand, produces higher levels of adipokines associated with insulin sensitivity, 
such as leptin and adiponectin.  Visceral WAT is more innervated by the SNS, possessing 
higher levels of beta-adrenergic receptor expression (Wahrenberg et al., 1989).  Thus, 
visceral WAT is more sensitive to catecholamine-induced lipolysis and less sensitive to 
alpha2- and insulin-dependent lipogenesis (Wahrenberg et al., 1989; Arner et al., 1990; 
Hellmer et al., 1992; Calle et al., 1999).  During noradrenaline stimulation, visceral 
adipocytes show a four- to fivefold increase in lipolysis when compared to subcutaneous 
adipocytes (Wahrenberg et al., 1989). 
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In contrast, subcutaneous WAT consists of smaller adipocytes, which have a 
greater capacity to absorb circulating fatty acids, a lower secretory activity of adipokines, 
and a greater sensitivity to insulin-dependent lipogenesis (i.e., low lipolytic activity) 
(Ibrahim, 2010). 
 
1.5 White Adipose Tissue and Obesity 
 Obesity results largely from an excess of white adipose tissue.  The different types 
of obesity are characterized by the regional distribution of excess WAT.  Excess visceral 
WAT is referred to as visceral or “apple-shaped” obesity, and an excess of subcutaneous 
WAT is called subcutaneous or “pear-shaped” obesity.  Visceral obesity is a major risk 
factor of the metabolic syndrome and its related diseases, such as insulin resistance, type 2 
diabetes, hyperlipidemia, and cardiovascular disease (Wang et al., 2005; Klein et al., 2007; 
Fox et al., 2007; Despres et al., 1995; Ross et al., 1996; Rexrode et al., 1998).  Individuals 
with visceral obesity have a metabolic profile characteristic of the metabolic syndrome: 
higher plasma levels of glucose, insulin, triglycerides, apolipoprotein B-containing 
lipoproteins, total cholesterol, and low-density lipoprotein (LDL) cholesterol (Despres et 
al., 1995).  Some individuals also display chronic low-grade inflammation caused by an 
increased secretion of pro-inflammatory cytokines, such as IL-6, IL-1, and TNFalpha 
(Alvehus et al., 2010).   
Unlike visceral obesity, subcutaneous obesity is associated with better overall 
metabolism and insulin sensitivity in both rodents and humans (Porter et al., 2009; Snijder 
et al., 2005; Miyazaki et al., 2002; Kim et al., 2007; Klein et al., 2004; Tanko et al., 2003).  
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Subcutaneous WAT is more responsive than visceral WAT to synthetic PPARgamma 
agonists, anti-diabetic drugs (Miyazaki et al., 2002).  Removal of subcutaneous (inguinal) 
WAT in mice results in increased lipid accumulation in visceral (mesenteric) WAT, 
increased plasma insulin levels, decreased insulin sensitivity, and increased TNFalpha.  
These abnormalities can be corrected by re-implantation of subcutaneous WAT (Ishikawa 
et al., 2004).  Moreover, implantation of subcutaneous WAT into the abdominal cavity of 
mice improves whole-body metabolism (Hocking et al., 2008, Tran et al., 2008).  A 
clinical study in women showed that the most severe insulin resistance was found in 
individuals with the highest percentage of visceral WAT and lowest percentage of 
subcutaneous WAT.  Furthermore, the most favorable metabolic profile was found in 
women with the lowest percentage of visceral WAT and highest percentage of 
subcutaneous WAT (Tanko et al., 2003). 
 
1.6 Brown Adipose Tissue  
 Brown adipose tissue is a unique organ found exclusively in mammals.  BAT is 
found abundantly in small mammals, hibernating animals, and human infants.  It is 
estimated that BAT evolved about 150 million years ago, providing mammals with the 
ability to maintain body temperature.  Heat production in response to environmental 
temperature or diet is referred to as adaptive thermogenesis (Enerback, 2010). 
 In small mammals, such as rodents, the major depot of BAT is located primarily in 
the interscapular region, whereas minor amounts exist in the axillary, cervical, mediastinal, 
and retroperitoneal regions.  Interestingly, brown-like adipocytes are also found 
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interspersed in WAT of adult animals that have been exposed to cold or chronically treated 
with beta3-adrenergic agonists.  In human infants, BAT is located in the axillary, cervical, 
perirenal, and periadrenal depots (Cannon and Nedergaard, 2004).  At birth, total BAT 
weighs about 150-250 g (2-5% of total body weight) and virtually disappears within the 
first years of childhood.  This decrease in BAT mass is not a matter of age per se, but a 
matter of size.  Compared to human adults, rodents and neonates have much higher 
surface-to-volume (S/V) ratios, making them more susceptible to cold.  BAT 
thermogenesis provides smaller animals with a protective mechanism against hypothermia.  
In response to the cold, energy expenditure (i.e., oxygen consumption) in rodents is 
increased by two- to fourfold (Cannon and Nedergaard, 2004).   
 
1.7 Beta-Adrenergic Stimulation of Brown Adipose Tissue 
 The amount and activity of brown adipose tissue are increased by prolonged 
exposure to cold or beta3-adrenergic agonists.  During periods of cold, temperature 
information is sensed by thermoceptors in the skin and transmitted to the hypothalamus.  
The hypothalamus then stimulates sympathetic nerves, which release catecholamines (e.g., 
norepinephrine) that bind to and activate G-protein coupled beta3-adrenergic receptors in 
BAT.  Gsalpha activates adenylyl cyclase, which catalyzes the conversion of ATP to cyclic 
AMP (cAMP).  cAMP activates protein kinase A (PKA), which stimulates lipolysis by 
phosphorylating hormone-sensitive lipase (HSL) and perilipin A.  Perilipin A, a lipid 
droplet-associated protein, coats lipid droplets and protects them from endogeneous 
lipases, such as HSL.  When perilipin A is phosphorylated, it dissociates from lipid 
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droplets, allowing HSL to bind and begin lipolysis.  Activation of HSL, the rate-limiting 
step of lipolysis, results in the breakdown of triglycerides into glycerol and free fatty acids. 
Free fatty acids (FFAs) serve as substrates for thermogenesis.  FFAs are converted 
to molecules of acyl-CoA, which are transported to the mitochondria by the carnitine 
shuttle.  FFAs undergo beta-oxidation in the mitochondrial matrix, generating molecules of 
acetyl-CoA.  Acetyl-CoA enters the tricarboxylic acid (TCA) cycle, leading to the 
formation of reduced electron carriers, NADH and FADH2.  NADH and FADH2 are 
oxidized as they pass electrons onto components of the electron transport chain, which are 
subsequently reduced.  The energy produced by these reduction-oxidation events is used to 
pump protons from the mitochondrial matrix to the intermembrane space.  This proton 
motive force is used in most cells to drive the conversion of ADP to ATP by ATP 
synthase.  However, in brown adipocytes, the mitochondrial respiratory chain is uncoupled 
from ATP synthesis by UCP1, dissipating the proton motive force as heat. 
 UCP1 is activated by fatty acids and inhibited by purines.  Two models have been 
proposed to explain the mechanistic actions of UCP1.  The first model proposes that UCP1 
is a true proton transporter, whereas the second model proposes that UCP1 is a fatty acid 
anion transporter (Skulechev et al., 1991, Garlid et al., 1998).  In the first model, UCP1 
acts as a typical proton channel—an integral mitochondrial membrane protein that allows 
the transport of protons across the inner mitochondrial membrane.  In the second model, 
UCP1 transports FFA anions out of the mitochondrial matrix, which become protonated in 
the acidic intermembrane space.  Neutral FFA-H diffuses back across the IMM and 
dissociates again in the more basic mitochondrial matrix.  The net effect is the return of 
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protons into the matrix.  Both models result in the dissipation of the proton gradient and 
the loss of potential energy as heat. 
 In addition to lipolysis and heat production via UCP1 activation, cell proliferation 
and mitochondrial biogenesis are induced by beta-adrenergic stimulation of BAT.  In 
rodents and humans, beta3-adrenoceptors are found abundantly in BAT and are responsible 
for driving thermogenesis.  Figure 1 summarizes the steps required for the activation of 
BAT thermogenesis (reviewed by Cannon and Nedergaard, 2004). 
 
 
 
 
Figure 1: Beta-Adrenergic Stimulation of BAT Thermogenesis (Cannon and 
Nedergaard, 2004) 
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1.8 Brown Adipose Tissue in Human Adults 
 
Until recently, brown adipose tissue was considered to be virtually nonexistent in 
human adults.  Because of size (e.g., smaller S/V ratio), indoor heating, and the use of 
warm clothing, human adults have a reduced need for BAT to protect themselves from the 
cold.  However, recent studies using PET/CT scans, which monitor glucose uptake using a 
radiolabeled glucose analogue (
18
F-fluorodeoxyglucose, or 
18
F-FDG), have demonstrated 
that human adults have significant amounts of metabolically active BAT.  Adult patients 
with pheochromocytomas (catecholamine-producing tumors) showing high 
18
F-FDG 
uptake in areas of putative BAT provided the first evidence that humans can develop BAT 
during adulthood (English et al., 1973; Ricquier et al., 1982; Bouillaud et al., 1983; Lean et 
al., 1986; Bouillaud et al., 1988).  Adult patients with rare BAT tumors called hibernomas 
have also been documented (Chatterton et al., 2002; Lin et al., 2005; Tsuchiya et al., 
2006).  More importantly, BAT has been found in healthy human adults (Hany et al., 2002; 
Cohade et al., 2003; Rousseau et al., 2006; Nedergaard et al., 2007; Cypress et al., 2009; 
van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009; Saito et al., 2009; Lee et al., 
2011).  Human BAT is located in several discrete areas, including the supraclavicular, 
cervical, paravertebral, mediastinal, para-aortic, and perirenal regions.  The presence of 
BAT in human adults has been verified histologically in the same anatomical regions 
(Saito et al., 2009, Virtanen et al., 2009, van Marken Lichtenbelt et al, 2009; Zingaretti et 
al., 2009; Lee et al., 2011). 
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Exposure to cold increases the amount of BAT in humans.  Although active BAT is 
detectable only in 3-7% of adults under thermoneutral conditions, this percentage increases 
up to 96% when individuals are subjected to a 2-hour cold exposure (van Marken 
Lichtenbelt et al., 2009).  One study showed that individuals during the winter months 
have greater amounts of BAT than the same individuals during the summer months (Saito 
et al., 2009; Au-Yong et al., 2009).  Another study demonstrated that outdoor workers 
from Finland have a higher prevalence of BAT surrounding major neck arteries than 
indoor workers of the same age (Huttunen et al., 1981).  These findings suggest that, 
although the amount of BAT is virtually undetectable in humans, it has a remarkable 
capacity to expand under certain stimuli, such as the cold. 
 
1.9 Brown Adipose Tissue and Obesity 
 In recent years, brown adipose tissue has been recognized for its potential and 
demonstrated anti-obesity properties.  In mice, BAT has been shown to protect against 
obesity, insulin resistance, and type 2 diabetes.  In response to overfeeding, BAT burns 
excess caloric intake to produce heat, a process called diet-induced thermogenesis.  Diet-
induced thermogenesis was first observed in mice fed “cafeteria” (high-fat, high-sugar) 
diets (Rothwell and Stock, 1979).  Cafeteria-fed mice consumed more calories, but gained 
less weight than expected from caloric intake.  The cafeteria diet stimulated the expansion 
and activation of BAT, as observed by increased BAT mass, oxygen consumption, 
respiratory enzyme activity, and UCP1 expression (Rothwell and Stock, 1979; Rothwell 
and Stock, 1983; Rothwell and Stock, 1986).  
 15 
 Loss of BAT activity, due to the removal of BAT, UCP1 expression, or beta-
adrenergic signaling, is associated with genetic and diet-induced obesity in rodents.  
Strains of genetically obese rodents, such as ob/ob and db/db mice and Zucker fa/fa rats, 
exhibit decreased sympathetic activity, UCP1 expression, and thermogenesis (Himms-
Hagen, 1983).  Surgical excision or denervation of BAT causes an accumulation of excess 
WAT and a reduction in energy expenditure (Dulloo and Miller, 1984).  Genetic ablation 
of BAT via expression of a targeted toxigene results in reduced energy expenditure, diet-
induced obesity, and other metabolic problems, such as hyperlipidemia, hyperinsulinemia, 
and insulin resistance (Lowell et al., 1993).  Deletion of UCP1 in mice causes increased 
weight gain when mice are housed at thermoneutrality.  The obesogenic effect observed in 
UCP1-knockout mice is accelerated under a high-fat diet due to impaired diet-induced 
thermogenesis (Liu et al., 2003).  Like UCP1-knockout mice, mice lacking all three beta-
adrenergic receptors (beta-less mice) develop massive obesity under a high-fat diet.  
Moreover, beta-less mice display a significant reduction in metabolic rate and have brown 
adipocytes that resemble white adipocytes (e.g., are unilocular and express leptin) 
(Bachman et al., 2002).  In humans, polymorphisms of UCP1 or combined polymorphisms 
of UCP1 and the beta3-adrenoceptor are associated with obesity and type 2 diabetes (Jia et 
al., 2010; Nagai et al., 2010; Kim and Lee, 2010). 
On the other hand, experimental increases of BAT, UCP1 expression, and 
adrenergic stimulation are associated with a lean and healthy phenotype in mice.  Mice 
with higher amounts of BAT gain less weight, are more insulin-sensitive, have lower levels 
of FFAs, and are protected from diabetes and other metabolic dysfunction.  Transgenic 
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mice overexpressing UCP1 are resistant to genetic and diet-induced obesity (Kopecky et 
al., 1995; Kopecky et al., 1996).  Targeted disruption of cell death-inducing DFF45-like 
effector A (Cidea), a negative regulator of UCP1 activity, results in a lean phenotype 
(Zhou et al., 2003).  Pharmalogical treatment of obese rodents with beta3-adrenergic 
agonists reduces obesity by preventing weight gain and stimulating weight loss (Yen et al., 
1984; Munro et al., 1987; Holloway et al., 1992; Largis et al., 1994; Yoshida et al., 1994; 
Yoshida et al., 1994).  These mice also display smaller white adipocytes, larger BAT mass, 
increased thermogenesis, and the induction of brown adipocytes in WAT (Munro et al., 
1987; Holloway et al., 1992). 
Altogether, these findings provide strong evidence that diet-induced thermogenesis 
is a critical mechanism underlying body weight homeostasis.  The anti-obesity properties 
of BAT in rodents and the presence of active BAT in human adults have raised the 
possibility that increasing the amount and/or activity of BAT might be a useful strategy in 
treating human obesity.  Whether or not human adults exhibit diet-induced thermogenesis 
is unknown.  Nevertheless, recent studies have found that the amount of BAT is inversely 
correlated with body mass index (i.e., leaner individuals have more BAT than obese 
individuals) (van Marken Kichtenbelt et al., 2009).  Scientists suggest that a relatively 
small amount of BAT could make a significant impact on energy balance.  It is estimated 
that just 50 g of BAT can raise a person’s daily energy expenditure by 20% (Rothwell and 
Stock, 1983).  Although the physiological role of BAT in humans is debated, the 
possibility to increase it artificially to treat obesity and related disorders cannot be 
excluded. 
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1.10 Development of Adipocytes 
Mesenchymal stem cells (MSCs) give rise to a variety of cell types, including 
adipocytes, myocytes, chondrocytes, and osteoblasts.  The exact number of intermediate 
stages between the MSC and the mature adipocyte is unknown.  However, it is proposed 
that MSCs first give rise to early fat precursors called adipoblasts, which later turn into 
preadipocytes that are competent to differentiate into mature adipocytes (Cornelius et al., 
1994).  The development of adipose tissue is orchestrated by a number of transcription 
factors.  The key transcription factors that promote WAT and BAT development are 
CCAAT/enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated 
receptors (PPARs).   
The C/EBPs are a family of basic-leucine zipper (bZIP) transcription factors, 
composed of six members C/EBPalpha to C/EBPzeta.  C/EBPalpha, C/EBPbeta, and 
C/EBPdelta are the only isoforms involved in adipogenesis (Wu et al., 1999).  C/EBPalpha 
regulates the transcription of several genes critical for adipose tissue function, such as 
adipose protein 2 (aP2), glucose transporter 4 (GLUT4), acetyl-CoA carboxylase, and 
stearyl-CoA desaturase (Darlington et al., 1995).  C/EBPbeta and C/EBPgamma induce the 
expression of PPARgamma and C/EBPalpha, two factors found to be sufficient in inducing 
adipogenesis in vitro (Farmer, 2006). 
   The PPARs are a family of nuclear receptors with three members: PPARalpha, 
PPARbeta, and PPARgamma.  PPARgamma is the isoform involved in adipocyte 
differentiation.  PPARgamma is required for normal lipid accumulation and activates the 
transcription of genes involved in fatty acid binding, uptake, and storage, such as aP2, 
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lipoprotein lipase (LPL), acyl-CoA synthase, and phosphoenolpyruvate carboxykinase 
(PEPCK) (Imai et al., 2004).  PPARgamma also promotes insulin-dependent glucose 
uptake by activating GLUT4.  For this reason, synthetic PPARgamma agonists, such as 
thiazolidinediones, are clinically used in the treatment of type 2 diabetes.  In brown 
adipocytes, PPARgamma induces the expression of UCP1 and mitochondrial genes, but 
only promotes thermogenesis when combined with adrenergic stimulation (Hansen and 
Kristiansen, 2006; Villarroya et al., 2007).   
 
1.11 Development of Classical Brown Adipocytes 
White and brown adipocytes have long been assumed to share a common 
developmental origin due to their common expression of genes involved in fat metabolism.  
However, recent studies have revealed that brown adipose tissue shares a common 
developmental origin with skeletal muscle, not white adipose tissue.  The link between 
BAT and skeletal muscle was first observed by lineage tracing using the homeobox gene 
Engrailed-1 (En1) (Atit et al., 2006).  Cells expressing En1, which are derived from the 
dermamyotome, give rise to dermis, skeletal muscle, and BAT (Atit et al., 2006).  
Microarray analyses have shown that muscle-specific mRNAs, such as myogenic factor D 
(myoD), myogenin (myoG), and muscle-specific microRNAs (myomiRs) are expressed in 
brown adipocytes (Timmons et al., 2007; Walden et al., 2009).  In vivo fate mapping has 
demonstrated that myogenic transcription factor 5 (Myf5) is expressed in precursors that 
develop into skeletal muscle and BAT, but not WAT (Seale et al., 2008).  These findings 
strongly suggest that BAT is more closely related to skeletal muscle than WAT. 
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PRD1-BF-1-RIZ1 homologous domain-containing protein 16 (PRDM16) has 
recently been described as the master regulator of BAT development (Seale et al., 2008).  
PRDM16 was first identified as a protein involved in human leukemic translocations (Moir 
et al., 1984; Bloomfield et al., 1985; Welborn et al., 1987; Secker-Walker et al., 1995).  A 
genome-wide analysis of transcription factors revealed that PRDM16 is involved in the 
expression of the BAT phenotype in vivo and in vitro (Seale et al., 2007).  Ectopic 
expression of PRDM16 in skeletal muscle progenitors induces the differentiation of brown 
adipocytes and simultaneously suppresses the development of skeletal muscle (Seale et al., 
2008).  Moreover, overexpression of PRDM16 induces mitochondrial biogenesis, 
activation of thermogenic genes, and cAMP-mediated uncoupled respiration (Seale et al., 
2008).  On the other hand, loss of PRDM16 from BAT precursors results in skeletal 
muscle development and reduced expression of BAT-selective genes (Seale et al., 2007; 
Seale et al., 2008).  From these studies, it was concluded that PRDM16 controls a 
bidirectional switch between brown adipocytes and skeletal myocytes.  However, recent 
studies have demonstrated that PRDM16 also regulates the development of brown-like 
adipocytes in white adipose tissue (Seale et al., 2007; Seale et al., 2010).  Transgenic 
expression of PRDM16 induces the expression of BAT-selective genes and the 
development of UCP1-expressing multilocular and unilocular cells in subcutaneous WAT 
(Seale et al., 2010). 
Bone morphogenic protein 7 (BMP7) also plays a key role in brown adipogenesis.  
BMP7 can activate the full thermogenic program of brown adipose tissue (Tseng et al., 
2008; Schultz et al., 2011) by inducing the transcription of early regulators of BAT 
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differentiation: PRDM16, PGC1alpha, UCP1, PPARgamma, and C/EBPs (Tseng et al., 
2008).  Moreover, BMP7 induces mitochondrial biogenesis (Tseng et al., 2008).   
 
1.12 Development of Beige Cells 
Clusters of brown-like adipocytes can be found interspersed in white adipose tissue 
(Enerback, 2009; Frontini and Cinti, 2010).  Brown-like adipocytes in WAT, also known 
as “beige” or “brite” (brown-in-white) cells (Ishibashi and Seale, 2010; Petrovic et al., 
2010), emerge in response to beta-adrenergic stimulation by cold or beta3-adrenoceptor 
agonists (Cousin et al., 1992; Collins et al., 1997; Ghorbani and Himms-Hagen, 1998; 
Guerra et al., 1998; Himms-Hagen et al., 2000; Xue et al., 2005; Seale et al., 2008) or by 
PPARgamma stimulation (Petrovic et al., 2010; Wilson-Fritch et al., 2004; Fukui et al., 
2000; Puri et al., 2008; Vernochet et al., 2009).  Beige cells contain the same hallmarks of 
classical brown adipocytes, including multilocular lipid storage, abundant mitochondria, 
expression of UCP1 and other thermogenic genes (Cidea, Elovl3, PGC1alpha, and 
PPARalpha), and thermogenic activity (Petrovic et al., 2010).  
Despite their similarities to classical brown adipocytes, beige cells appear to derive 
from a different origin.  Beige cells do not have the same gene expression profile as 
classical brown adipocytes, including the expression of transcription factors highly 
expressed in BAT, such as Zic1, Lhx8, Meox2, and PRDM16
1
 (Timmons et al., 2007; 
Petrovic et al., 2010; Schulz et al., 2011), and muscle-specific genes, such as myogenin, 
                                                 
1
 PRDM16 and Zic1 were not expressed in beige cells from epidydimal WAT (Timmons et al., 2007; Schulz 
et al., 2011), but were expressed in inguinal WAT (Seale et al., 2011; Schulz et al., 2011). 
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myoD, and myomiRs (Timmons et al., 2007; Walden et al., 2009; Petrovic et al., 2010).  
Moreover, beige cells do not express Myf5, a molecular marker for cells of the skeletal 
muscle/brown adipose tissue lineage (Timmons et al., 2007; Seale et al., 2008).  They do, 
however, express known classical WAT genes, such as Igfbp3, Tcf21, DPT, and Hoxc9 
(Timmons et al., 2007; Petrovic et al., 2010; Schulz et al., 2011).   
The increased development of beige cells appears to reverse or protect against 
obesity in rodents.  Mouse strains resistant to diet-induced obesity, such as the A/J strain, 
exhibit increased expression of beige cells (Collins et al., 1997).  Transgenic mice 
expressing PRDM16, which promotes beige cell development in subcutaneous WAT, are 
protected from obesity and metabolic dysfunction (Seale et al., 2011).  The induction of 
beige cells is correlated with the reduction of obesity in mice treated with beta3-adrenergic 
agonists (Collins et al., 1997; Ghorbani and Himms-Hagen, 1998).  In humans, the 
emergence of beige cells in subcutaneous WAT is correlated with increased insulin 
sensitivity (Yang et al., 2003; Timmons and Pedersen, 2009).  For example, insulin-
resistant patients exhibit reduced expression of BAT-selective genes in subcutaneous WAT 
(Yang et al., 2003).  Beige cells are detected by a large induction of UCP1 at the mRNA 
level and a corresponding increase in UCP1 protein, as revealed by immunohistochemistry.  
In both lean and obese patients, UCP1 expression has been found in biopsies from visceral 
WAT (Oberkofler et al., 1997).  It is estimated that WAT in humans contain about one 
brown-like adipocyte for every 100-200 white adipocytes (Oberkofler et al., 1997). 
Inguinal WAT, a type of subcutaneous WAT, is more susceptible to “browning” 
than epidydimal WAT, a visceral depot.  Immunohistochemistry shows that inguinal WAT 
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contains more clusters of UCP1-positive multilocular cells than epidydimal WAT, which is 
almost entirely made of UCP1-negative unilocular cells (Guerra et al., 1998; Petrovic et 
al., 2010; Seale et al., 2011).  These morphological differences are likely due to differences 
in gene expression.  BAT-selective genes, such as UCP1, PRDM16, Cidea, Cox8b, and 
Elovl3, are highly expressed in inguinal WAT and found at low or undetectable levels in 
epidydimal WAT (Seale et al., 2011).   
Recently, several factors have been shown to influence the beige cell phenotype, 
including PGC1alpha, FoxC2, COX2, pRb, p107, RIP140, LXRalpha, and Twist1. 
PPARgamma co-activator-1 alpha (PGC1alpha) is a PPARgamma-interacting 
protein found abundantly in highly oxidative tissues, including BAT, slow twitch muscle 
fibers, heart, brain, and liver.  Exogenous addition of PGC1alpha via adenovirus in human 
white adipocytes from the subcutaneous depot induces UCP1 expression by increasing the 
transcriptional activity of PPARgamma on the UCP1 promoter (Tiraby et al., 2003).  
PGC1alpha also activates the expression of mitochondrial enzymes of the respiratory chain 
and increases mitochondrial biogenesis (Puigserver et al., 1998; Uldry et al., 2006).  
Interestingly, brown preadipocytes lacking PGC1alpha are still capable of differentiating 
(Uldry et al., 2006).  Mice lacking PGC1alpha exhibit low UCP1 expression and cold 
sensitivity (Lin et al., 2004). 
Forkhead box C2 (FoxC2) is a key regulator of adipocyte metabolism.  In mice 
overexpressing FoxC2 in WAT and BAT, WAT was reduced and had acquired a BAT-like 
histology, whereas BAT was hypertrophic (Cederberg et al., 2001).  Moreover, UCP1 was 
induced in WAT.  These transgenic mice expressing FoxC2 were protected against diet-
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induced obesity and insulin resistance.  In wild-type mice fed a high-fat diet, FoxC2 
mRNA levels were upregulated and worked to counteract diet-induced obesity (Cederberg 
et al., 2001).  Mice expressing only one FoxC2 allele had decreased BAT mass (Cederberg 
et al., 2001).  In insulin-resistant patients, the expression of FoxC2, along with BAT-
selective genes, is reduced in subcutaneous WAT (Yang et al., 2003). 
pRB is a member of the repressors of E2F (Rb) family of transcription factors, 
which play key roles in the regulation of the cell cycle and the differentiation of many 
tissues.  pRB is differentially regulated during adipocyte differentiation (Hansen et al., 
2004).  Mouse fibroblasts lacking pRB differentiate into mitochondria-rich brown 
adipocytes with a gene expression pattern characteristic of BAT (Dali-Youcef et al., 2007).  
p107, another member of the Rb family, has been implicated in the development of 
beige cells.  Mice lacking p107, another member of the Rb family, have WAT depots that 
contain multilocular adipocytes expressing elevated levels of thermogenic genes, 
PGC1alpha and UCP1 (Scime et al., 2005).  Upon cold exposure, pRB is inhibited via 
phosphorylation, which results in the induction of UCP1 expression in BAT (Scime et al., 
2005).  Treatment of white adipocytes with a beta3-adrenoceptor agonist downregulates 
pRB expression, resulting in the transformation of WAT to BAT (Scime et al., 2005). 
RIP140, a transcriptional co-repressor for nuclear receptors, acts as a negative 
regulator of whole-body glucose tolerance and energy expenditure.  Mice lacking RIP140 
are lean, show resistance to diet-induced obesity and hepatic steatosis, and have increased 
oxygen consumption (Leonardsson et al., 2004).  Expression of genes involved in energy 
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dissipation and mitochondrial uncoupling (UCP1) is markedly increased (Leonardsson et 
al., 2004). 
Liver X receptor alpha (LXRalpha) is a direct transcriptional inhibitor of UCP1 
expression.  LXRalpha recruits RIP140, a transcriptional co-repressor for nuclear 
receptors, and together they bind to the PPARgamma/PGC1alpha response element of the 
UCP1 promoter (Wang et al., 2008).  
Twist1 suppresses mitochondrial metabolism and uncoupling by inhibiting the 
binding of PGC1alpha to the promoters of its target genes.  Mice expressing only one 
functional Twist1 allele are obesity-resistant and exhibit altered mitochondrial metabolism 
in BAT (Pan et al., 2009).  Transgenic mice expressing Twist-1 in adipose tissue are prone 
to diet-induced obesity (Pan et al., 2009). 
Cyclooxygenase 2 (COX2) is a rate-limiting enzyme in prostaglandin synthesis.  
COX2 has recently been identified as a downstream effector of beta-adrenergic signaling 
in WAT and is required for the induction of beige cells and UCP1 expression 
(Vegiopoulos et al., 2010; Madsen et al., 2010).  Overexpression of COX2 in WAT results 
in beige cell development, increased energy expenditure, and protection against diet-
induced obesity (Vegiopoulos et al., 2010).  Moreover, increased prostaglandin levels in 
mesenchymal progenitors shift differentiation toward a brown adipocyte phenotype 
(Vegiopoulos et al., 2010).   
 Figure 2 summarizes the differentiation pathways of white, brown, and beige 
adipocytes from mesenchymal stem cells. 
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Figure 2: Differentiation of White, Brown, and Beige Adipocytes (modified from 
Fruhbeck et al., 2009) 
 
 26 
1.13 Molecular Signature of Brown and Beige Adipose Tissue 
The following genes are molecular markers of brown adipose tissue that possess 
either a structural or regulatory function required for fully differentiated BAT.  It has 
previously been shown that these genes are highly expressed in subcutaneous WAT in 
mice (Seale et al., 2011).  In the present study, we investigated the expression levels of 
these BAT-selective genes in WAT. 
UCP1 
Uncoupling protein 1 (UCP1), formerly known as thermogenin, belongs to a family 
of mitochondrial carrier proteins.  UCP1 is predominantly expressed in brown adipocytes 
and is required for the thermogenic activity of brown adipose tissue.  UCP1 is inhibited by 
purine nucleotides (e.g., GDP, ADP) and is activated by free fatty acids that are released 
following beta-adrenergic stimulation.  UCP1 significantly reduces the rate of ATP 
production by uncoupling the respiratory chain, dissipating energy in the form of heat 
(reviewed in Cannon and Nedergaard, 2004).  In white adipose tissue, UCP1 mRNA and 
protein are present at very low levels and increases in response to cold exposure or 
treatment with beta-adrenoceptor agonists (Cousin et al., 1992; Ghorbani and Himms-
Hagen, 1997; Guerra et al., 1998; Himms-Hagen et al., 2000; Huttunen et al., 1981; Xue et 
al., 2005).  Multilocular cells that express UCP1 in WAT are characterized as beige cells. 
PRDM16 
PRD1-BF-1-RIZ1 homologous domain-containing protein 16 (PRDM16) is the 
master regulator of brown adipocyte differentiation.  PRDM16 interacts with co-activators 
PGC1alpha and PGC1beta to activate transcription of BAT-selective genes, such as UCP1, 
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PGC1alpha, and Dio2 and suppress the expression of muscle-specific genes, such as 
MyoD, MyoG, myosin heavy chain (MyHC), and muscle creatine kinase (MCK) (Seale et 
al., 2007).  Moreover, PRDM16 interacts with co-repressors CtBP1 and CtBP2 to inhibit 
WAT-selective genes, such as angiotensinogen, resistin, and WDNM1-like (Kaijimura et 
al., 2008).  Transgenic expression of PRDM16 in preadipocytes isolated from inguinal 
WAT induces the expression of UCP1 and other BAT-selective genes, such as Cidea, 
Elovl3, and Cox8b (Seale et al., 2011). 
Cidea 
 Cell death-inducing DFF45-like effector A (Cidea) was first described as an 
apoptotic protein (Inohara et al., 1998).  In adipose tissue, Cidea is a lipid droplet-
associated protein that plays a role in fat storage (Puri et al., 2008).  In mice, mRNA levels 
of Cidea are high in interscapular BAT but undetectable in epidydimal WAT (Zhou et al., 
2003).  Cidea is a negative regulator of lipolysis in WAT (Nordstrom et al., 2005) and 
UCP1 uncoupling activity in BAT (Zhou et al., 2003; Lin and Li, 2004).  Mice treated with 
a PPARgamma agonist, rosiglitazone, have increased levels of Cidea and contain 
multilocular UCP1-expressing adipocytes (beige cells) in inguinal WAT (Petrovic et al., 
2010).  
Cox8b 
Cytochrome c oxidase subunit VIIIb (Cox8b) is a component of the cytochrome c 
oxidase (COX) complex, which catalyzes the last step of mitochondrial respiration (i.e., 
the conversion of oxygen to water).   Cox8b is induced by PRDM16 in brown and beige 
adipocytes (Wilson-Fritch et al., 2004; Kaijimura et al., 2008; Kaijimura et al., 2009; 
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Barbatelli et al., 2010; Seale et al., 2011).  Although Cox8b is highly expressed in BAT, its 
role in BAT is poorly understood. 
Elovl3 
 Elovl3 is an elongase enzyme of very long chain fatty acids.  Elovl3 is more highly 
expressed in brown adipocytes than white adipocytes.  Treatment with PPARgamma 
agonist rosiglitazone, together with norepinephrine, enhances Elovl3 mRNA levels 
(Jorgensen et all, 2007).  Interestingly, rosiglitazone treatment elevates Elovl3 levels to 
higher levels in white adipocytes than in brown adipocytes.  Cold exposure significantly 
increases Elovl3 expression in inguinal WAT, not epidydimal WAT, suggesting that 
inguinal WAT is more susceptible to “browning” (Jakobsson et al., 2005). 
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CHAPTER 2: BACKGROUND OF STUDY 
 
Our lab has previously made the novel observation that Tyk2-knockout (Tyk2-/-) 
mice become spontaneously obese and develop many symptoms of the metabolic 
syndrome (Gornicka, 2009).  We hypothesize that the obese phenotype observed in Tyk2-
knockout mice is due to decreased energy expenditure, resulting from impaired brown 
adipocyte differentiation in classical brown adipose tissue.  The major focus of this study is 
to determine if Tyk2 plays a role in the development of brown-like adipocytes (beige cells) 
in classical white adipose tissue.   
 
2.1 Tyrosine Kinase 2 (Tyk2)  
Until now, Tyk2 has not been previously associated with obesity.  There are no 
published reports on a role of Tyk2 in the regulation of metabolic homeostasis.  Tyrosine 
Kinase 2 (Tyk2) is a non-receptor tyrosine kinase of the Janus kinase (JAK) family.  Tyk2 
was the first member of the JAK family to be identified, with an important role in type I 
interferon (IFN) signaling (Krolewski et al., 1990).  Mutant cell lines lacking Tyk2 have 
impaired IFNalpha/beta signaling, observed by the absence of Stat3 activation and a slight 
reduction in Stat1 and Stat2 activation.  Type I IFN signaling is restored after 
reconstitution of Tyk2 (Karaghiosoff et al., 2000). 
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Tyk2 plays a critical role in cytokine signaling, particularly of IL-6, IL-10, IL-12, 
and IL-23 (reviewed by Watford and O’Shea, 2006; Figure 3).  Tyk2, together with Jak2, 
is required for the differentiation of IFNgamma-producing Th1 cells, mediated by IL-12.  
Tyk2 is also needed for Th17 cell differentiation, which is activated by IL-23. 
 
 
Figure 3: Tyk2-Dependent Cytokine Signaling (Watford and O’Shea, 2006) 
 
Tyk2-deficient mice are viable and fertile (Karaghiosoff et al., 2000).  However, 
they display a number of defects when challenged with viral and bacterial pathogens.  
Impaired type I IFN signaling in Tyk2-/- mice causes resistance to lipopolysaccharide 
(LPS)-induced toxic shock and impaired LPS-induced NO production in macrophages 
(Karaghiosoff et al., 2000; Karaghiosoff et al., 2003; Kamezaki et al., 2004).  Impaired IL-
12 signaling in Tyk2-/- mice causes defects in the differentiation of IFNgamma-producing 
Th1 cells (Muller et al., 1993; Watling et al., 1993) and the activation of natural killer 
(NK) cells (Shimoda et al., 2002).  These defects result in an enhanced susceptibility to 
infection with pathogens, such as the lymphocytic choriomeningitis virus (LCMV) 
 31 
(Karaghiosoff et al., 2000), Leishmania (Schleicher et al., 2004), and the Abelson murine 
leukemia virus (A-MuLV) (Stoiber et al., 2004).  Moreover, the lack of Th1 response is 
accompanied by an enhanced Th2 response that accelerates allergic reactions, such as lung 
inflammation (Seto et al., 2003).  
Only a single patient with Tyk2 deficiency has been identified so far (Minegishi et 
al., 2006).  Similar to Tyk2-deficient mice, the patient lacking Tyk2 presented defects in 
cytokine signaling and developed multiple, opportunistic infections of various organs.  
However, defects in the Tyk2-/- patient were broader and more profound compared to the 
mice.  This is likely due to the fact that type I IFN signaling was completely absent in the 
Tyk2-/- patient, whereas only a partial defect in type I IFN signaling was observed in 
Tyk2-/- mice.  The reason for this discrepancy is unknown.  The Tyk2-/- patient suffered 
from severe atopic dermatitis and was clinically diagnosed with hyperimmunoglobulin E 
(hyperIgE) syndrome (HIES), a primary immunodeficiency defined by the accumulation of 
IgE resulting from an enhanced Th2 response.  
 
2.2 The JAK/STAT Signaling Pathway 
The JAK/STAT pathway plays a critical role in the signaling of a wide variety of 
cytokines that regulate cell development and homeostasis (reviewed by Aaronson and 
Horvath, 2002; Igaz et al., 2001; Keisseleva et al., 2002; O’Shea et al., 2002; Shuai and 
Liu, 2003). 
The Janus kinase (JAK) family consists of four members: Jak1, Jak2, Jak3, and 
Tyk2.  Each JAK has a unique function and, with the exception of Jak3, all JAKs are 
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ubiquitously expressed in mammals.  JAKs are relatively large proteins containing over 
1000 amino acids with a molecular weight of 120-140 kDa.  All JAKs have a similar 
domain structure consisting of seven JAK homology (JH) domains.  A catalytically active 
kinase domain (JH1), located at the carboxyl-terminus, phosphorylates specific tyrosine 
residues of its substrates.  Adjacent to the kinase domain is a catalytically inactive 
pseudokinase or kinase-like domain (JH2), which has been suggested to negatively 
regulate kinase activity.  The tandem structure of these two kinase domains is a hallmark of 
JAKs.  For this reason, JAKs were named after the two-faced Roman god, Janus.  
Following the pseudokinase domain is a Src homology 2 (SH2)-like domain (JH3-JH5) 
that plays a structural role for receptor interaction.  At the amino-terminus of the protein is 
a 4.1, ezrin, radixin, moesin (FERM) domain (JH6-JH7), which mediates the binding 
between JAKs and cytokine receptors and also regulates kinase activity. 
 
 (a)  
(b)  
Figure 4: Domain Structure of JAKs and STATs 
Primary structure of (a) JAKs (Yamaoka et al., 2004) and (b) STATs (Levy and 
Darnell, 2002). 
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The major substrates for JAKs are the signal transducers and activators of 
transcription (STAT) proteins.  STATs are latent cytoplasmic transcription factors that 
mediate a wide range of actions induced by cytokines.  There are seven known STATs: 
Stat1, Stat2, Stat3, Stat4, Stat5a and Stat5b, and Stat6.  STAT proteins contain 750-900 
amino acids and are 80-95 kDa in molecular weight.  STATs share structurally and 
functionally conserved domains: an N-terminal regulatory domain (NTD), a coiled-coil 
(CC) domain, a DNA-binding domain (DBD), a Src homology 2 (SH2) domain, a linker 
domain (LD), and a C-terminal transactivation domain (TAD).  At the carboxyl-terminus, 
STAT proteins have a conserved tyrosine residue, whose phosphorylation is required for 
dimerization and DNA binding.  Some STATs, such as Stat3, also contain a conserved 
serine residue, whose phosphorylation is required for maximal transactivation. 
The JAK/STAT pathway consists of a series of tyrosine phosphorylation events 
(summarized in Figure 5).  JAKs are loosely associated with cytokine receptors in the 
absence of ligands.  When a cytokine binds to its receptor, homo- or heterodimerization of 
the cytokine receptor occurs.  Dimerization of the receptor brings receptor-associated JAKs 
in close proximity to each other.  The JAKs transphosphorylate each other at specific 
tyrosine residues, and in turn tyrosine phosphorylate the cytoplasmic domain of the 
receptor.  The phosphorylated tyrosines on the receptor provide docking sites for SH2-
containing STATs.  STATs bind to the phosphorylated receptor and are then 
phosphorylated by activated JAKs.  This causes the STATs to dissociate from the receptor 
and form homo- or heterodimers with each other.  Activated STATs then translocate into 
the nucleus and bind to specific DNA sequences found in the promoter region of target 
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genes: an interferon-stimulated response element (ISRE) or a gamma-interferon activation 
site (GAS). 
Cytokine signaling through the JAK/STAT pathway regulates multiple cellular 
responses, including cell growth, survival, and differentiation.  Mutations in the 
JAK/STAT pathway have been implicated in several diseases, such as Hodgkin lymphoma, 
myeloproliferative disorders, and other cancers (Jatiani et al., 2010).    
 
 
 
Figure 5: General Overview of the JAK/STAT Pathway (modified from 
Schindler, 2002) 
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2.3 Role of Tyk2 in Obesity 
 
Our lab has previously found that Tyk2-knockout (Tyk2-/-) mice on a SV129 
background become spontaneously obese (Figure 6a) and develop symptoms characteristic 
of the metabolic syndrome (Gornicka, 2009).  Mice lacking Tyk2 presented impaired 
glucose tolerance and insulin resistance, which are major risk factors for type 2 diabetes.  
These phenotypic changes were accompanied by changes in mRNA expression of genes 
involved in glucose metabolism, lipid metabolism, and the coordination of metabolic 
responses in the hypothalamus (leptin and neuropeptides). 
The obese phenotype in Tyk2-knockout mice was also demonstrated in two 
additional mouse strains: C57BL/6 and BALB/c (Derecka, 2011).  Mice on a C57BL/6 
background are described as an obesity-prone strain, whereas BALB/c mice are resistant to 
diet-induced obesity.  These knockout strains developed high-fat diet-induced obesity and 
displayed abnormal glucose tolerance.  However, they did not appear to be hyperphagic. 
 
2.4 Role of Tyk2 in Brown Adipose Tissue Development 
A lack of increased food intake with increasing body weight suggested that Tyk2-
knockout mice have a defect in energy expenditure.  mRNA expression of thermogenic 
genes (UCP1, PRDM16, and Cidea) was downregulated in Tyk2-knockout mice (C57BL/6 
and BALB/c) (Derecka, 2011).  Moreover, the expression of PPARalpha, which activates 
transcription of beta-oxidation enzymes, was also decreased.  There were no significant 
changes in RNAs encoding common adipose genes, such as PPARgamma and PGC1alpha, 
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suggesting that Tyk2 functions selectively in the development and thermogenic activity of 
BAT. 
Histological analysis of BAT revealed large differences in lipid accumulation 
between wild-type and Tyk2-knockout mice.  Tyk2-/- BAT contained large adipocytes 
with unilocular lipid droplets, resembling WAT (Figure 6b).  This altered morphology is 
likely a consequence of the observed downregulation of BAT-selective genes.   
Brown preadipocytes were isolated from neonatal wild-type and Tyk2-knockout 
mice and subjected to in vitro differentiation with induction media consisting of 
dexamethasone, insulin, and 3-isobutyl-1-methylxanthine (IBMX).  Oil Red O staining, 
which stains triglyerides and lipids, was performed to detect mature adipocytes.  Tyk2-/- 
brown preadipocytes failed to differentiate in vitro, compared to wild-type preadipocytes 
(Figure 6c). 
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 (a)    
(b)    
(c)  
 
Figure 6: Tyk2 in Obesity and Brown Adipose Tissue Development  
(a) Picture representation of body weight of 12-month-old WT and Tyk2-/- 
mice (Gornicka, 2009).  (b) Hematoxylin and eosin (H&E) stain of BAT 
from WT and Tyk2-/- mice (Derecka, 2011).  (c) Oil red O stain of WT and 
Tyk2-/- BAT preadipocytes differentiated in vitro (Derecka, 2011).  
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2.5 Research Aims 
 Tyk2 is required for the development of classical brown adipocytes.  The focus of 
this study was to determine if Tyk2 also plays a role in the development of beige cells, 
brown-like adipocytes that can be found in classical white adipose tissue.  In the present 
study, we focused on mRNA expression of BAT-selective genes in two types of white 
adipose tissue: epidydimal WAT (a visceral depot) and inguinal WAT (a subcutaneous 
depot).  A recent study has shown that inguinal WAT, not epidydimal WAT, expresses 
BAT-selective genes UCP1, PRDM16, Cidea, Cox8b, and Elovl3 (Seale et al., 2011).  The 
development of beige cells in mice expressing or lacking Tyk2 was assessed by the mRNA 
expression of these BAT-selective genes in subcutaneous WAT. 
 
Specific Aims 
1. To confirm the expression of BAT-selective genes in subcutaneous WAT of wild-
type mice 
2. To identify if there is a role of Tyk2 in the development of beige cells in 
subcutaneous WAT
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Mice 
All mice were bred and maintained in the animal facilities at Virginia 
Commonwealth University School of Medicine, according to regulations established by 
the Institutional Animal Care and Use Committee (IACUC).  Tyk2-deficient mice on a 
C57BL/6 background were kindly provided by Dr. Ana Gamero from the Department of 
Biochemistry of Temple University School of Medicine in Philadelphia, PA.  Tyk2 
knockouts were generated by Dr. Kazuya Shimoda and colleagues from the Department 
of Internal Medicine of Kyushu University in Fukuoka, Japan.  The disruption of Tyk2 
expression was performed by electroporation of embryonic stem cells with a vector that 
carried a neomycin resistance cassette that replaced the first coding exon of the Tyk2 
gene.  10-12 week old wild-type and Tyk2-deficient male mice (C57BL/6 background) 
were used for all experiments.   
 
3.2 Dissections 
 The following dissections were made: interscapular BAT (iBAT) on the dorsal 
side of the mouse between the shoulder blades; inguinal WAT (ingWAT) underneath the 
skin surrounding the pelvis, from the back to the front of the thighs; epidydimal WAT 
(epidWAT) surrounding the epidydimal tubes above the testes; mesenteric WAT 
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(mWAT) attached to the intestines; and retroperitoneal WAT (rWAT) behind the 
kidneys.  The tissues were flash frozen and stored at -80°C.  
 
 
Figure 7: Adipose Depots Dissected in Study (modified from Cinti, 2009) 
 
3.3 Isolation of total RNA and cDNA synthesis 
 50 g of each tissue were homogenized in 1 ml of TRI Reagent (Molecular 
Research, Cincinnati, OH) using a Glas-Col Homogenizer (Cole-Parmer, Vernon Hills, 
IL).  Homogenates were transferred to 1.5 ml tubes, and 200 ul of chloroform was added.  
Tubes were vortexed for at least 30 seconds, incubated at room temperature for 5 
minutes, and centrifuged at 12,000 x g for 15 minutes at 4°C.  The upper aqueous phase 
was transferred to fresh 1.5 ml tubes, and an equal amount of 100% isopropanol (1:1) 
was added.  Tubes were vortexed briefly and incubated at -20°C for at least one hour or 
overnight.  The samples were centrifuged at 12,000 x g for 15 minutes at 4°C.  The RNA 
pellets were washed once with 70% ethanol, air-dried for at least 15 minutes at 37°C, and 
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resuspended with DEPC-treated water.  Extra chloroform extraction and ethanol wash 
steps were performed to eliminate possible phenol contamination and improve the 
efficiency of cDNA synthesis.  Isolated RNA samples were treated with DNase 
(Promega, Madison, WI) for 1 hour at 37°C, followed by an addition of stop solution and 
incubation at 65°C for 10 minutes.  Using a spectrophotometer, the concentration of RNA 
samples was determined by measuring absorbance at 260 nm, and the purity by the 260 
nm/280 nm absorbance ratio.  2 ug of total RNA from each sample were reverse 
transcribed using the Tetro cDNA Synthesis Kit (Bioline, Taunton, MA).   
 
3.4 Quantitative PCR 
 mRNA levels of the genes of interest were analyzed by real-time quantitative 
PCR (qPCR) using the SensiMix SYBR and Fluorescein Kit (Bioline, Taunton, MA) 
according to manufacturer’s instructions.  The reaction mixtures were prepared as 
follows: for measuring TBP mRNA (internal control)—12.5 ul of SYBR and Fluorescein 
mix, 1 ul of 5 uM forward primer, 1 ul of 5 uM reverse primer, 5 ul of cDNA (final 
concentration 5 ng/ul), 5.5 ul of H2O (total volume 25 ul); for measuring mRNA levels 
of target genes—12.5 ul SYBR and Fluorescein mix, 2.5 ul of 5 uM forward primer, 2.5 
ul of 5 uM reverse primer, 5 ul of cDNA (final concentration 5 ng/ul), 2.5 ul of H2O 
(total volume 25 ul).  All samples were assayed in duplicates and analyzed using the 
CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA) using the following 
amplification conditions: 1 cycle of 95°C for 10 minutes, 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute.  The results were analyzed according to the deltaC(t) 
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method using a reference gene (variation of Livak method).  Briefly, to calculate relative 
mRNA expression, expression of the gene of interest (target) was first normalized to a 
reference gene (TBP mRNA): expression = 2^[Ct(TBP mRNA)-Ct(target)].  This was 
applied to each adipose tissue of all experimental groups of mice.  The gene expression 
ratio of inguinal WAT to epidydimal WAT was calculated by setting the expression of 
the target gene in epidydimal WAT to 1.  Gene expression was also measured by 
normalizing the mRNA levels of the epidydimal WAT and inguinal WAT of each data 
set to the mRNA levels of epidydimal WAT in wild-type mice under basal conditions. 
 
 
 
Table 2: Primers Used for Real-Time qPCR Analysis 
 
3.5 Statistical analysis 
 Results are presented as the mean ± standard error (SE).  Statistical comparison 
was performed using the two-tailed Student’s t-test.  A P-value less than 0.05 (P<0.05) 
was considered as statistically significant and annotated by *.  Other statistically 
significant P-values are annotated as follows: **P<0.01 and ***P<0.001.
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CHAPTER 4: RESULTS 
 
4.1 BAT-selective genes are expressed in subcutaneous WAT of wild-type mice 
Considering the differences between WAT depots in their propensity to develop 
beige cells, we wanted to determine which depots selectively express UCP1 and other 
molecular markers of fully differentiated BAT.  We dissected five different types of 
adipose tissues—epidydimal WAT (epidWAT), mesenteric WAT (mWAT), 
retroperitoneal WAT (rWAT), inguinal WAT (ingWAT), and interscapular BAT 
(iBAT)—from 10-12 week old male mice on a C57BL/6 background.  From these 
tissues, we isolated RNA and synthesized cDNA for gene expression analysis by real-
time qPCR.  We first looked at mRNA expression levels of UCP1 because of its unique 
expression in brown adipocytes.  UCP1 levels of each depot were compared to those of 
epidydimal WAT, the “purest” visceral WAT depot.  As expected, we found robust 
expression of UCP1 in interscapular BAT, a 600-fold enrichment relative to epidydimal 
WAT (P<0.001) (Figure 8a).  The two visceral depots that were tested, mesenteric WAT 
and retroperitoneal WAT, did not express UCP1, whereas the subcutaneous depot, 
inguinal WAT, highly expressed UCP1 at a level 35-fold higher than epidydimal WAT 
(P<0.001) (Figure 8a).  Inguinal WAT also exhibited large 20- to 100-fold increases in 
Cidea (20-fold), Cox8b (100-fold), and Elovl3 (20-fold) expression, and a slight but 
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significant increase in PRDM16 (1.3-fold) (Figure 8b).  All increases were statistically 
significant (P<0.05).   
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(a) 
 
(b) 
 
 
Figure 8: BAT-selective genes are expressed in subcutaneous WAT of wild-type 
mice 
Real-time qPCR analysis of (a) UCP1 mRNA levels in epidydimal WAT (epidWAT), 
mesenteric WAT (mWAT), retroperitoneal WAT (rWAT), inguinal WAT (ingWAT), and 
interscapular BAT (iBAT) of 10-12 week old male WT mice fed a regular chow diet and 
(b) mRNA levels of BAT-selective genes (UCP1, Cidea, Cox8b, Elovl3, and PRDM16) 
in epidWAT and ingWAT of WT mice.  Values are mean ± SE (n = 4-5 mice per group).  
*P<0.05, ***P<0.001. 
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4.2 Expression of BAT-selective genes is reduced in subcutaneous WAT of Tyk2-/- 
mice 
Our lab has previously found that Tyk2-knockout (Tyk2-/-) mice become obese 
with age and have impaired brown adipose tissue.  Because Tyk2 is involved in classical 
BAT development, we wanted to determine if Tyk2 is also involved in the development 
of beige cells.  We focused our attention on epidydimal WAT and inguinal WAT, which 
showed clear differences in UCP1 expression in wild-type mice (Figure 8a).  Using real-
time qPCR, we measured fold enrichment of UCP1, Cidea, Cox8b, Elovl3, and PRDM16 
in Tyk2-/- inguinal WAT relative to epidydimal WAT, and compared these values with 
those observed in wild-type mice (Figure 8b).  We found that BAT-selective genes were 
significantly downregulated in subcutaneous WAT of Tyk2-/- mice compared to wild-
type mice: Cidea by 7-fold, Cox8b by 10-fold, Elovl3 by 90-fold, and PRDM16 by 3-fold 
(all P-values <0.05) (Figure 9).  The most notable change was demonstrated by a 175-
fold decrease in UCP1 expression (P<0.01). 
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Figure 9: Expression of BAT-selective genes is reduced in subcutaneous WAT of 
Tyk2-/- mice 
Real-time qPCR analysis of mRNA levels of BAT-selective genes (UCP1, Cidea, Cox8b, 
Elovl3, and PRDM16) in epidWAT and ingWAT of 10-12 week old male WT and Tyk2-
/- mice fed a regular chow diet.  Values are mean ± SE (n = 4-5 mice per group).  
*P<0.05, **P<0.01. 
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4.3 BAT-selective genes are induced in Tyk2-/- subcutaneous WAT by acute 
starvation  
 To verify the changes in expression that we observed in Figure 9, we repeated the 
experiment with another set of Tyk2-knockout mice.  Much to our surprise, both 
experiments yielded different results.  It was later realized that the second set of knockout 
mice was starved overnight for 12 hours in preparation for metabolic experiments.  While 
the first group of mice (unstarved Tyk2-/-) showed significant decreases in BAT-
selective gene expression (Figure 9), the second group of mice (starved Tyk2-/-) 
displayed high expression of BAT-selective genes in their subcutaneous WAT (Figure 
10).  UCP1 was increased by 110-fold, Cidea by 110-fold, Cox8b by 230-fold, Elovl3 by 
5-fold, and PRDM16 by 2-fold.   
To determine if this starvation effect was due to the lack of Tyk2, we looked at 
gene expression in subcutaneous WAT of wild-type mice under starved conditions.  We 
found that there were no significant differences in BAT-selective gene levels between 
unstarved and starved wild-type mice (except for Cidea) (Figure 10).  Thus, acute 
starvation causes an induction of BAT-selective genes only in Tyk2-/- subcutaneous 
WAT. 
One caveat about our measurements is that the mRNA levels of each mouse were 
normalized to the mRNA levels of its own epidydimal WAT, under the assumption that 
BAT-selective gene expression would be constantly low in this depot.  When we 
compared mRNA levels of epidydimal WAT between wild-type and Tyk2-/- mice, we 
unexpectedly saw a 10-fold induction of UCP1 in Tyk2-/- epidydimal WAT compared to 
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wild-type epidydimal WAT (Figure 10b).  Although statistically non-significant, this 
induction of UCP1 in epidydimal WAT accounted for the large decrease in the 
ingWAT/epidWAT expression ratio of UCP1 in Tyk2-/- mice, shown in Figure 9.  After 
correcting for this, the 175-fold decrease of UCP1 in Tyk2-/- inguinal WAT became a 
35-fold decrease (Figure 10b).  Interestingly, the level of UCP1 (27-fold enrichment) in 
Tyk2-/- inguinal WAT after 12 hours of starvation was approximately equal to the UCP1 
level observed in inguinal WAT of unstarved wild-type mice (35-fold enrichment) 
(Figure 10b). 
 50 
 
(a)      (b) 
 
(c)      (d) 
 
(e)      (f) 
 
 
Figure 10: BAT-selective genes are induced in Tyk2-/- subcutaneous WAT by acute 
starvation 
Real-time qPCR analysis of mRNA levels of BAT-selective genes: (a-b) UCP1, (c) 
Cidea, (d) Cox8b, (e) Elovl3, and (f) PRDM16 of 10-12 week old male WT mice fed a 
regular chow diet (unstarved) or fasted for 12 hours (starved).  Values are mean ± SE (n = 
4-5 mice per group).  *P<0.05, **P<0.01, ***P<0.001. 
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CHAPTER 5: DISCUSSION 
 
 Our lab has previously discovered that Tyk2, an important mediator of cytokine 
signaling, promotes the development of classical brown adipose tissue (Gornicka, 2009; 
Derecka, 2011). The focus of this study was to determine if Tyk2 also plays a role in the 
development of beige cells, brown-like adipocytes that can be found in classical white 
adipose tissue. 
In the present study, we focused on mRNA expression of BAT-selective genes in 
two types of white adipose tissue: epidydimal WAT (a visceral depot) and inguinal WAT 
(a subcutaneous depot).  A recent study has shown that inguinal WAT, not epidydimal 
WAT, expresses BAT-selective genes UCP1, PRDM16, Cidea, Cox8b, and Elovl3 (Seale 
et al., 2011).  The development of beige cells in mice expressing or lacking Tyk2 was 
assessed by the mRNA expression of these BAT-selective genes in subcutaneous WAT. 
UCP1 is uniquely expressed in brown adipose tissue and can therefore serve as a marker 
for brown-like adipocytes (beige cells) that are present in white adipose tissue.  The other 
BAT-selective genes (Cidea, Cox8b, Elovl3, and PRDM16) were also evaluated to 
support any significant changes observed in UCP1 expression.  
Our first aim was to confirm the expression of BAT-selective genes in 
subcutaneous WAT of wild-type mice.  Using real-time qPCR, we found that, in mice 
housed at ambient temperature (22°C), UCP1 mRNA is enriched in subcutaneous WAT 
 52 
(inguinal depot) compared to the levels observed in visceral WAT (epidydimal, 
mesenteric, and retroperitoneal depots) (Figure 8a).  Moreover, Cidea, Cox8b, Elovl3, 
and PRDM16 were enriched in inguinal WAT relative to epidydimal WAT (Figure 8b).  
Our data mimicked the same expression patterns observed by Seale et al. (2011). 
 Our second aim was to identify if there is a role of Tyk2 in the development of 
beige cells in subcutaneous WAT.  We examined BAT-selective mRNA levels in 
inguinal WAT of Tyk2-/- mice and found that they were downregulated compared to 
mRNA levels in epidydimal WAT (Figure 9).  Surprisingly, we found that epidydimal 
WAT of Tyk2-/- mice displayed higher UCP1 expression than epidydimal WAT of WT 
mice (Figure 10b); however, it is unclear whether UCP1 is truly induced in Tyk2-/- 
epidydimal WAT.  For this purpose, we have recently isolated tissues from WT and 
Tyk2-/- mice to repeat this experiment. 
Unexpectedly, we found that a 12-hour starvation can induce beige cell 
development in Tyk2-/- subcutaneous WAT.  In starved Tyk2-/- mice, mRNAs of UCP1, 
Cidea, Cox8b, Elovl3, and PRDM16 were enriched in inguinal WAT relative to their 
mRNA levels in epidydimal WAT (Figure 10).  A similar induction of BAT-selective 
genes occurred with combined starvation and cold exposure (data not shown).  In wild-
type mice, however, there appeared to be no significant changes in gene expression in the 
inguinal depot upon starvation (Figure 10).   
To our knowledge, there are no published reports on the effects of starvation on 
beige cell formation.  In classical brown adipose tissue, it has been shown that starvation 
decreases sympathetic activity, resulting in decreased UCP1 expression and thermogenic 
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activity (Hayashi and Nagasaka, 1983; Tulp, 1983; Rothwell et al., 1984; Trayhurn and 
Jennings, 1986; Trayhurn and Jennings, 1988; Champigny and Ricquier, et al., 1990; 
Ohno et al., 1993).  However, beige cells, which are derived from a different 
developmental origin, may respond to starvation entirely differently.  
Indeed, starvation does not have the same effects on white adipose tissue as it 
does on brown adipose tissue.  It has been shown that fasting and other stress stimuli, 
such as severe exercise and cold exposure, increase sympathetic activity in WAT, which 
then stimulates lipid breakdown and mobilization (Migliorini et al., 1997; Giordano et al., 
2005).  As a result, more free fatty acids are released which can activate UCP1.  This, 
however, does not explain why starvation would cause beige cell development in the first 
place.  It seems counterintuitive for an organism to increase its energy expenditure during 
times of energy need.  We postulate that this induction of beige cells in Tyk2-/- mice may 
be a compensatory mechanism for the decrease in classical BAT function resulting from 
the combined effect of starvation and defective beta-oxidation already present in Tyk2-/- 
mice.  However, more experiments need to be done to validate this speculation. 
Overall, this thesis demonstrates that Tyk2 is involved in the development of 
beige cells under ambient conditions.  Moreover, it demonstrates that the need for Tyk2 
in beige cell development can be bypassed by acute starvation.  In the future, it will be 
important to determine if the BAT-selective mRNA levels observed in this study are 
accompanied by the appearance (or lack thereof) of UCP1-expressing multilocular cells 
in subcutaneous WAT.  For this purpose, we have recently fixed and paraffin-blocked 
different adipose tissues, epidydimal WAT, inguinal WAT, and interscapular BAT, for 
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immunohistochemistry using an anti-UCP1 antibody.  It would also be interesting to see 
if the starvation-induced expression of beige cells in Tyk2-/- mice would still be present 
after the stress stimulus is removed (i.e., after mice are re-fed).  Since Tyk2 plays a role 
in the development of both brown and beige adipocytes, understanding the molecular 
mechanisms of Tyk2 in these two processes may be important in discovering new 
therapies against obesity and related diseases.
 55 
 
 
 
 
 
 
 
 
 
LITERATURE CITED 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
 
 
 
 
LITERATURE CITED 
 
Aaronson DS and Horvath CM.  A road map for those who know JAK-STAT.  Science 
296, 1653-1655, 2002. 
 
Andersson JC and Walley AJ.  The Contribution of Heredity to Clinical Obesity.  In: 
Obesity Before Birth: Maternal and prenatal influences on the offspring (R.H. Lustig, ed.), 
2011. 
  
Alvehus M, Buren J, Sjostrom M, Goedecke J, Olsson T.  The human visceral fat depot has 
a unique inflammatory profile.  Obesity (Silver Spring) 18: 879-883, 2010. 
 
Arner P, Hellstrom L, Wahrenberg H, and Bronnegard M.  Beta-adrenoceptor expression 
in human fat cells from different regions.  J Clin Invest 86:1595-1600, 1990. 
 
Atit R, Sgaier SK, Mohamed OA, Taketo MM, Dufort D, Joyner AL, Niswander L, and 
Conion RA.  Beta-catenin activation is necessary and sufficient to specific dorsal dermal 
fate.  Dev Biol 296:164-176, 2006.   
 
Au-Yong ITH, Thorn N, Ganatra R, Perkins AC, and Symonds ME.  Brown Adipose 
Tissue and Seasonal Variation in Humans.  Diabetes 58: 2583-2587, 2009. 
 
Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, and Lowell BB.  
Beta-AR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance.  
Science 297: 843-845, 2002. 
 
Bloomfield CD, Garson OM, Volin L, Knuutila S, and de la Chapelle A.  t(1;3)(p36;q21) 
in acute nonlymphocytic leukemia: a new cytogenetic-clinicopathologic association.  
Blood 66: 1409-1413, 1985. 
 
Bouillaud F, Combes-George M, Ricquier D.  Mitochondria of adult human brown adipose 
tissue contain a 32000-Mr uncoupling protein. Biosci Rep 3: 775-780, 1983. 
 
Bouillaud F, Villarroya F, Hentz E, Raimbault S, Cassard AM, Ricquier D.  Detection of 
brown adipose tissue uncoupling protein mRNA in adult patients by a human genomic 
probe.  Clin Sci (Lond) 75: 21-27, 1988. 
 57 
Calle CE, Thun Mi, Petrelli JM, Rodriguez C, Heath CWJ.  Body mass index and mortality 
in a prospective cohort of U.S. adults.  N Engl J Med 341: 1097-1105, 1999. 
 
Cannon B and Nedergaard J.  Brown adipose tissue: function and physiological 
significance.  Physiol Rev 84: 277-359, 2004. 
 
Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, and Enerback S.  FOXC2 is 
a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced 
insulin resistance.  Cell 106: 563-573, 2001. 
 
Centers for Disease Control and Prevention.  “Overweight and Obesity.”  Retrieved from 
www.cdc.gov.  2010. 
 
Champigny O and Ricquier D.  Effects of Fasting and Refeeding on the Level of 
Uncoupling Protein mRNA in Rat Brown Adipose Tissue: Evidence for Diet-Induced and 
Cold-Induced Responses.  American Institute of Nutrition, pp. 1730-1736, 1990.   
   
Chatterton BE, Mensforth D, Coventry BJ, and Cohen P.  Hibernoma: intense uptake seen 
on Tc-99m tetrofosmin and FDG positron emission tomographic scanning.  Clin Nucl Med 
27: 369-370, 2002. 
 
Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, and Parker MG.  RIP140-
targeted repression of gene expression in adipocytes.  Mol Cell Biol 25: 9383-9391, 2005. 
 
Cinti S.  Transdifferentiation properties of adipocytes in the Adipose Organ.  Am J Physiol 
Endocrinol Metab (Epub), 2009. 
 
Cohade C, Osman M, Pannu HK, and Wahl RL.  Uptake in Supraclavicular Area Fat 
(“USA-FAT”): Description on 18F-FDG PET/CT.  J Nucl Med 44:170-176, 2003. 
 
Collins S, Daniel KW, Petro AE, and Surwit RS.  Strain-specific response to beta3-
adrenergic receptor agonist treatment of diet-induced obesity in mice.  Endocrinology 138: 
405-413, 1997. 
 
Cornelius P, MacDougald OA, and Lane MD.  Regulation of Adipocyte Development.  
Annu. Rev Nutr 14: 99-129, 1994. 
 
Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L, and Casteilla L.  
Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological 
characterization.  J Cell Sci 103(pt 4): 931-942, 1992. 
 
 58 
Cypress AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, 
Tseng T, Doria A, Kolodny GM, and Kahn CR.  Identification and Importance of Brown 
Adipose Tissue in Adult Humans.  N Engl J Med 360: 1509-1517, 2009. 
 
Dahle MK, Gronning LM, Cederberg A, Blomhoff HK, Miura N, Enerback S, Tasken KA, 
and Tasken K.  Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha 
subunit of cAMP-dependent protein kinase include release of transcriptionl repression and 
activation by protein kinase B alpha and cAMP.  J Biol Chem 277: 22902-22908, 2002. 
 
Dali-Youcef N, Mataki C, Coste A, Messaddeq N, Giroud S, Blanc S, Koehl C, Champy 
MF, Chambon P, Fajas L, Metzger D, Schoonjans K, and Auwerx J.  Adipose tissue-
specific inactivation of the retinoblastoma protein protects against diabesity because of 
increased energy expenditure.  Proc Natl Acad Sci USA 104: 10703-10708, 2007. 
 
Darlington GJ, Wang N, and Hanson RW.  C/EBPalpha: a critical regulator of genes 
governing integrative metabolic processes.  Curr Opin Genet Dev 5: 565-570, 1995. 
 
Derecka M.  To Be or Not To Be Fat: A Novel Role of JAK/STAT Pathway in Brown Fat 
Development and Preventing Obesity.  Ph.D. Thesis, Virginia Commonwealth University, 
Richmond, 2011. 
 
Despres JP, Lemieux S, Lamarche B, Prud’homme D, Moorjani S, Brun LD, Gagne C, and 
Lupien PJ.  The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity 
and therapeutic implications.  Int J Obes Relat Metab Disord 19 Suppl 1:S76-S86, 1995. 
 
Dulloo AG and Miller DS.  Energy balance following sympathetic denervation of brown 
adipose tissue.  Can J Physiol Pharmacol 62: 235-240, 1984. 
 
Enerback S.  The origins of brown adipose tissue.  N Engl J Med 360: 2021-2023, 2009. 
 
Enerback S.  Human Brown Adipose Tissue.  Cell Metab 11:248-252, 2010. 
 
English JT, Patel SK, Flanagan MJ.  Association of phaeochromocytomas with brown fat 
tumours.  Radiology 107: 279-283, 1973. 
 
Farmer SR.  Transcriptional control of adipocyte formation.  Cell Metab 4: 263-273, 2006. 
 
Ferrie JE, Head J, Shipley MJ, Vahtera J, Marmot MG, and Kivimaki M.  BMI, Obesity, 
and Sickness Absence in the Whitehall II Study.  Obesity 15: 1554-1564, 2007. 
 
Finkelstein EA, Trogdon JG, Cohen JW, and Dietz W.  Annual medical spending 
attributable to obesity: payer- and service-specific estimates.  Health Aff (Millwood): 28: 
w822-831, 2009. 
 59 
 
Frontini A and Cinti S.  Distribution and development of brown adipocytes in the murine 
and human adipose organ.  Cell Metab 11: 253-256, 2010. 
 
Frubeck G, Becerril S, Sainz N, Garrastachu P, and Garcia-Velloso MJ.  BAT: a new 
target for human obesity?  Trends Pharmacol Sci 30: 387-396, 2009. 
 
Fukui Y, Masui S, Osada S, Umesono K, and Motojima K.  A new thiazolidinedione, NC-
2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and 
induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.  Diabetes 49: 
759-767, 2000.   
 
Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C, Vasan RS, 
Murabito JM, Meigs JM, Cupples LA, D’Agostino RB, and O’Donnell CJ.  Abdominal 
visceral and subcutaneous adipose tissue compartments: association with metabolic risk 
factors in the Framingham Heart Study.  Circulation116: 39-48, 2007. 
 
Garlid KD, Jaburek M, and Jezek P.  The mechanism of proton transport mediated by 
mitochondrial uncoupling proteins.  FEBS Lett 438: 10-14, 1998. 
 
Garlid KD, Orosz DE, Modriansky M, Vassanelli S, and Jezek P.  On the Mechanism of 
Fatty Acid-induced Proton Transport by Mitochondrial Uncoupling Protein.  J Biol Chem 
271: 2615-2620, 1996. 
 
Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, Boucher J, Lewis C, 
and Kahn CR.  Evidence for a role of developmental genes in the origin of obesity and 
body fat distribution.  Proc Natl Acad Sci USA 2006;103(17):6676-6681. 
 
Ghorbani M and Himms-Hagen J.  Appearance of brown adipocytes in white adipose 
tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats.  Int 
J Obes Relat Metab Disord 21:465-475, 1998. 
 
Giordano A, Frontini A, Murano I, Tonello C, Marino MA, Carruba MO, Nisoli E, and 
Cinti S.  Regional-dependent increase of sympathetic innervation in rat white adipose 
tissue during prolonged fasting.  J Histochem Cytochem 53: 679-687, 2005. 
 
Gornicka A.  Deficiency in the tyrosine kinase Tyk2 in mice facilitates the development of 
metabolic syndrome.  In: Immunology.  Cleveland: Cleveland Clinic Foundation, 2009. 
 
Grundy SM.  A constellation of complications: the metabolic syndrome.  Clin Cornerstone 
7: 36-45 (2005). 
 
 60 
Guerra C, Koza RA, Yamashita H, Walsh K, and Kozak LP.  Emergence of brown 
adipocytes in white fat in mice is under genetic control: Effects on body weight and 
adiposity.  J Clin Invest 102: 412-420, 1998. 
 
Hamdy O, Porramatikul S, and Al-Ozairi E.  Metabolic obesity: the paradox between 
visceral and subcutaneous fat.  Curr Diabetes Rev 2: 367-373, 2006. 
 
Hansen JB, Jorgensen C, Petersen RK, Hallenborg P, De Matteis R, Boye HA, Petrovic N, 
Enerback S, Nedergaard J, Cinti S, te Riele H, and Kristiansen K.  Retinoblastoma protein 
functions as a molecular switch determining white versus brown adipocyte differentiation.  
Proc Natl Acad Sci USA 101: 4112-4117, 2004. 
 
Hansen JB and Kristiansen K.  Regulatory circuits controlling white versus brown 
adipocyte differentiation.  Biochem J 398: 153-168, 2006. 
 
Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, and von Schulthess GK.  
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and 
upper chest region.  Eur J Nucl Mol Imaging 29: 1393-1398, 2002. 
 
Hayashi M and Nagasaka T.  Suppression of norepinephrine-induced thermogenesis in 
brown adipose tissue by fasting.  Am J Physiol 245: E582-E586, 1983. 
 
Hellmer H, Marcus C, Sonnefield T, and Arner P.  Mechanisms for differences in lipolysis 
between human subcutaneous and omental fat cells.  J Clin Endocrinol Metab 75: 15-20, 
1992. 
 
Himms-Hagen J.  Brown adipose tissue thermogenesis in obese animals.  Nutr Rev 41: 
261-267, 1983. 
 
Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, and Cinti S.  
Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white 
adipocytes.  Am J Physiol Cell Physiol 279: C670-C681, 2000. 
 
Hocking SL, Chisholm DJ, and James DE.  Studies of regional adipose transplantation 
reveal a unique and beneficial interaction between subcutaneous adipose tissue and the 
intra-abdominal compartment. Diabetologia 51: 900-902, 2008. 
 
Holloway BR, Howe R, Rao BS, and Stribling D.  ICI D7114, a novel selective 
adrenoceptor agonist of brown fat and thermogenesis.  Am J Clin Nutr 55: 262S-264S, 
1992. 
 
Huttunen P, Hirvonen J, and Kinnula V.  The occurrence of brown adipose tissue in 
outdoor workers.  Eur J Appl Physiol Occup Physiol 46: 339-345, 1981. 
 61 
 
Ibrahim MM.  Subcutaneous and visceral adipose tissue: structural and functional 
differences.  Obes Rev 11: 11-18, 2010. 
 
Igaz P, Toth S, and Falus A.  Biological and clinical significance of the JAK-STAT 
pathway; lessons from knockout mice.  Inflamm Res 50: 435-441, 2001. 
 
Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark 
M, Desvergne B, Wahli W, Chambon P, and Metzger D.  Peroxisome proliferator-
activated receptor gamma is required in mature white and brown adipocytes for their 
survival in the mouse.  Proc Natl Acad Sci USA 101: 4543-4547, 2004. 
 
Inohara N, Koseki T, Chen S, Wu X, and Nunez G.  CIDE, a novel family of cell death 
activators with homology to the 45 kDa subunit of the DNA fragmentation factor.  EMBO 
J 17: 2526-2533, 1998. 
 
Ishibashi J and Seale P.  Beige Can Be Slimming.  Science 328: 1113-1114, 2010. 
 
Ishikawa K, Takahasi K, Bujo H, et al.  Regulating subcutaneous fat accumulation alters 
insulin sensitivity.  Diabetes 53(suppl2): A408, 2004. 
 
Jakobsson A, Jorgensen JA, and Jacobsson A.  Differential regulation of fatty acid 
elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased 
fatty acid oxidation.  Am J Physiol Endocrinol Metab 289: E517-E526, 2005. 
 
Jatiani SS, Baker SJ, Silverman LR, and Reddy EP.  JAK/STAT Pathways in Cytokine 
Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies.  Genes 
Cancer 1: 979-993, 2010. 
 
Jia JJ, Tian YB, Cao ZH, Tao LL, Zhang X, Gao SZ, Ge CR, Lin QY, and Joi M.  The 
polymorphisms of UCP1 genes associated with fat metabolism, obesity, and diabetes.  Mol 
Biol Rep 37: 1513-1522, 2010. 
 
Jorgensen JA, Zadravec D, and Jacobsson A.  Norepinephrine and rosiglitazone 
synergistically induce Elovl3 expression in brown adipocytes.  Am J Physiol Endocrinol 
Metab 293: E1159-68, 2007. 
 
Kaijimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas JL, Chin S, 
Tempst P, Lazar MA, and Spiegelman BM.  Regulation of the brown and white fat gene 
programs through a PRDM16/CtBP transcriptional complex.  Genes Dev 22: 1397-1409, 
2008. 
 
 62 
Kaijimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, and Spiegelman BM.  
Initiation of myoblast to brown fat switch by a PRDM16-C/EBPbeta transcriptional 
complex.  Nature 460: 1154-1158, 2009. 
 
Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayam K, and Harada M.  The role of 
Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals.  Int Immunol 16: 1173-1179, 
2004. 
 
Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, McCoy B, 
Bogdan C, Decker T, Brem G, Pfeffer K, and Muller M.  Partial impairment of cytokine 
responses in Tyk2-deficient mice.  Immunity 13: 549-560, 2000. 
 
Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, Donabauer B, 
Reichart U, Kolbe T, Bogdan C, Leanderson T, Levy D, Decker T, and Muller M.  Central 
role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.  Nat 
Immunol 4: 471-477, 2003. 
 
Kisseleva T, Bhattacharya S, Braunstein J, and Schindler CW.  Signaling through the 
JAK/STAT pathway, recent advances and future challenges.  Gene 285: 1-24, 2002. 
 
Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, and Mohammed BS.  
Absense of an effect of liposuction on insulin action and risk factors for coronary heart 
disease.  N Engl J Med 350: 2549-2557, 2004. 
 
Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R, et al.  
Waist circumferences and cardiometabolic risk: a consensus statement from shaping 
America’s health: Association for Weight Management and Obesity Prevention; NAASO, 
the Obesity Society; the American Society for Nutrition; and the American Diabetes 
Association.  Am J Clin Nutr 85: 1197-1202. 
 
Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, 
Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, 
Schwartz GJ, and Scherer PE.  Obesity-associated improvements in metabolic profile 
through expansion of adipose tissue.  J Clin Invest 117: 261-2637, 2007. 
 
Kim JY and Lee SS.  The effects of uncoupling protein 1 and beta3-adrenergic receptor 
gene polymorphisms on weight loss and lipid profiles in obese women.  Int J Vitam Nutr 
Res 80: 87-96, 2010. 
 
Kopecky J, Clarke G, Enerback S, Spiegelman B, and Kozak LP.  Expression of the 
mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic 
obesity.  J Clin Invest 96: 2914-2923, 1995. 
 
 63 
Kopecky J, Hodny Z, Rossmiesl M, Syrovy I, Kozak LP.  Reduction of dietary obesity in 
aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am J Physiol 270: 
E768-E775, 1996. 
 
Krolewski JJ, Lee R, Eddy R, Shows TB, and Dalla-Favera R.  Identification and 
chromosomal mapping of new human tyrosine kinase genes.  Oncogene 5: 277-282, 1990. 
 
Largis EE, Burns MG, Muenkel HA, Dolan JA, Claus TH.  Antidiabetic and antiobesity 
effects of a highly selective beta3-adrenoceptor agonist (CL 316243).  Drug Dev Res 32: 
69-76, 1994. 
 
Lean ME, James WP, Jennings G, and Trayhurn P.  Brown adipose tissue in patients with 
pheochromocytoma.  Int J Obes 10: 219-227, 1986. 
 
Lee P, Greenfield JR, Ho KK, and Fulham MJ.  A critical appraisal of the prevalence and 
metabolic significance of brown adipose tissue in adult humans. Am J Physiol Endocrinol 
Metab 299: E601-E606, 2010. 
 
Lee P, Zhao JT, Swarbrick MM, Gracie G, Bova R, Greenfield JR, Freund J, and Ho KK.  
High Prevalence of Brown Adipose Tissue in Adult Humans.  J Clin Endocrinol Metab 
(Epub), 2011. 
 
Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Medina-
Gomez G, Vidal-Pulg A, White R, and Parker MG.  Nuclear receptor corepressor RIP140 
regulates fat accumulation.  Proc Natl Acad Sci USA 101: 8437-8442, 2004. 
 
Levy DE and Darnell JE, Jr.  Stats: transcriptional control and biological impact.  Nat Rev 
Mol Cell Biol 3: 651-662, 2002. 
 
Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, 
Vianna CR, Reznick RM, et al.  Defects in adaptive energy metabolism with CNS-linked 
hyperactivity in PGC-1alpha null mice.  Cell 119: 121-135, 2004. 
 
Lin D, Jacobs M, Percy T, Dowdy Y, Mantil J.  High 2-deoxy-2[F-18]fluoro-D-glucose 
uptake on positron emission tomography in hibernoma originally thought to be myxoid 
liposarcoma. Mol Imaging Biol 7: 2001-2002, 2005. 
 
Lin SC and Li P.  CIDE-A, a novel link between brown adipose tissue and obesity.  Trends 
Mol Med 10: 434-439, 2004. 
 
Liu X, Rossmeisl M, McClaine J, and Kozak L.  Paradoxical resistance to diet-induced 
obesity in UCP1-deficient mice.  J Clin Invest 111: 399-407, 2003.   
 
 64 
Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, 
Flier JS.  Development of obesity in transgenic mice after genetic ablation of brown 
adipose tissue.  Nature 366: 740-742, 1993. 
 
Madsen Lise, et al.  UCP1 Induction during Recruitment of Brown Adipocytes in White 
Adipose Tissue Is Dependent on Cyclooxygenase Activity.  PLoS One 5: e11391, 2010. 
 
Marin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm B, Sjostrom L, 
Bjorntorp P.  The morphology and metabolism of intra-abdominal adipose tissue in men.  
Metabolism 41: 1241-1248, 1992. 
 
Migliorini RH, Garofalo MA, and Kettelhut IC.  Increased sympathetic activity in rat white 
adipose tissue during prolonged fasting.  Am J Physiol 272(2 Pt 2): R656-R661, 1997. 
 
Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, 
Kawamura N, Ariga T, Kaneko H, Kondo N, et al.  Human tyrosine kinase 2 deficiency 
reveals its requisite roles in multiple cytokine signals involved in innate and acquired 
immunity.  Immunity 25: 745-755, 2006. 
 
Miyazaki Y, Mahankali A, Matsuda M, et al.  Effect of Pioglitazone on abdominal fat 
distribution and insulin sensitivity in type 2 diabetic patients.  J Clin Endocrinol Metab 87: 
2784-2791, 2002. 
 
Moir DJ, Jones PA, Pearson J, Duncan JR, Cook P, Buckle VJ.  A new translocation, 
t(1;3)(p36;q21), in myelodysplastic disorders.  Blood 64: 553-555, 1984. 
 
Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, 
Barbieri G, Witthuhn BA, Schindler C, et al.  The protein tyrosine kinase JAK1 
complements defects in interferon-alpha/beta and -gamma signal transduction.  Nature 
366: 129-135, 1993. 
 
Munro JF, Chapman BJ, Robb GH, Zed C.  Clinical studies with thermogenic drugs.  In: 
Recent advances in obesity research (Berry EM, Eliahou SH, Shafir E, eds.), pp. 155-159, 
Libbey, London, 1987. 
 
Nagai N, Sakane N, Tsuzaki K, and Moritani T.  UCP1 genetic polymorphism (-3826 A/G) 
diminishes resting energy expenditure and thermoregulatory sympathetic nervous system 
activity in young females.  Int J Obes (London) (Epub), 2010. 
 
National Heart, Lung, and Blood Institute.  Clinical Guidelines on the Identification, 
Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.  
Retrieved from www.nhlbi.nih.gov.  1998. 
 
 65 
Nedergaard J, Bengtsson T, and Cannon B.  Unexpected evidence for active brown adipose 
tissue in adult humans.  Am J Physiol 293: E444-E452, 2007. 
 
Nordstrom EA, Ryden M, Backlund EC, Dahlman I, Kaaman M, Blomgyist L, Cannon B, 
Nedergaard J, and Arner P.  A human-specific role of cell death-inducing DFFA (DNA 
fragmentation factor alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity.  
Diabetes 54: 1726-1734, 2005. 
 
Oberkofler H, Dallinger G, Liu YM, Hell E, Krempler F, and Patsch W.  Uncoupling 
protein gene: quantification of expression levels in adipose tissues of obese and non-obese 
humans.  J Lipid Res 38: 2125-2133, 1997. 
 
Ohno T, Ohinata H, Ogawa K, and Kuroshima A.  Fasting-induced modifications of fatty 
acids composition in brown adipose tissue.  J Therm Biol 19: 135-140, 1994. 
 
O’Shea JJ, Gadina M, and Schreiber RD.  Cytokine signaling in 2002: new surprises in the 
Jak/Stat pathway.  Cell 109(suppl.): S121-S131, 2002. 
 
Pan D, Fujimoto M, Lopes A, and Wang YX.  Twist-1 is a PPARdelta-inducible, negative-
feedback regulator of PGC-1alpha in brown fat metabolism.  Cell 137: 73-86, 2009. 
 
Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J.  Chronic 
peroxisome proliferator-activated receptor gamma (PPARgamma) activation of 
epidydimally derived white adipocyte cultures reveals a population of thermogenically 
competent, UCP1-containing adipocytes molecularly distinct from classic brown 
adipocytes.  J Biol Chem 285:7153-7164, 2010.   
 
Porter SA, Massaro JM, Hoffman U, Vasan RS, O’Donnel CJ, and Fox CS.  Abdominal 
subcutaneous adipose tissue: a protective fat depot?  Diabetes Care 32: 1068-1075, 2009. 
 
Powelka AM, et al.  Suppression of oxidative metabolism and mitochondrial biogenesis by 
the transcriptional corepressor RIP140 in mouse adipocytes.  J Clin Invest 116: 125-136, 
2006. 
 
Puigserver P, Wu Z, Park CW, Graves R, Wright M, and Spiegelman BM.  A Cold-
Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis.  Cell 92: 
829-839, 1998. 
 
Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, Chawia A, Chouinard M, Lin C, 
Burkart A, Corvera S, Perugini RA, and Czech MP.  Cidea is associated with lipid droplets 
and insulin sensitivity in humans.  Proc Natl Acad Sci USA105: 7833-7838, 2008. 
 
 66 
Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MH, Willet 
WC, and Manson JE.  Abdominal adiposity and coronary heart disease in women.  JAMA 
280: 1843-1848, 1998. 
 
Ricquier D, Nechad M, Mory G.  Ultrastructural and biochemical characterization of 
human brown adipose tissue in pheochromocytoma.  J Clin Endocrinol Metab 54: 803-
807, 1982. 
 
Ross R, Fortier L, and Hudson R.  Separate associations between visceral and 
subcutaneous adipose tissue distribution, insulin and glucose levels in obese women.  
Diabetes Care 19: 1404-1411, 1996. 
 
Rothwell NJ and Stock MJ.  A role for brown adipose tissue in diet-induced 
thermogenesis. Nature (London) 281: 31-35, 1979. 
 
Rothwell NJ and Stock MJ.  Diet-induced thermogenesis.  In: Mammalian Thermogenesis 
(Girardier L and Stock MJ, eds.), pp. 208-233, Chapman & Hall, London, 1983. 
 
Rothwell NJ and Stock MJ.  Luxuskonsumption, diet-induced thermogenesis and brown 
fat: the case in favour.  Clin Sci (London) 64: 19-23, 1983. 
 
Rothwell NJ, Saville ME, and Stock MJ.  Brown fat activity in fasted and refed rats.  
Biosci Rep 4: 351-357, 1984. 
 
Rothwell NJ and Stock MJ.  Brown adipose tissue and diet-induced thermogenesis.  In: 
Brown Adipose Tissue (Trayhurn P and Nicholls DG, eds.), pp. 269-298, Edward Arnold, 
London, 1986. 
 
Rousseau C, Bourbouloux E, Campion L, Fleury N, Bridji B, Chatal JF, Resche I, and 
Campone M.  Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT 
scans.  Eur J Nucl Med Mol Imaging 33: 785-791, 2006. 
 
Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, 
Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M.  High incidence 
of metabolically active brown adipose tissue in healthy adult humans: effects of cold 
exposure and adiposity.  Diabetes 58: 1526-1531, 2009. 
 
Schindler CW.  JAK-STAT signaling in human disease.  J Clin Invest 109: 1133-1137, 
2002. 
 
Schmidt I.  Metabolic Diseases: the Environment Determines the Odds, Even for Genes.  
News Physiol Sci 17: 115-121, 2002.  
 
 67 
Schulz TJ, Huang TL, Tran TT, Zhang H, Townsend KL, Shadrach JL, Cerletti M, 
McDougall LE, Giorgadze N, Tchkonia T, Schrier D, Falb D, Kirland JL, Wagers AJ, and 
Tseng Y.  Identification of inducible brown adipocyte progenitors residing in skeletal 
muscle and white fat.  Proc Natl Acad Sci USA 108: 143-148, 2011. 
 
Scime A, et al.  Rb and p107 regulate preadipocyte differentiation into white versus brown 
fat through repression of PGC-1alpha.  Cell Metab 2: 283-295, 2005. 
 
Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, Tavernier G, Langin D, and 
Spiegelman BM.  Transcriptional control of brown fat determination by PRDM16.  Cell 
Metab 6: 38-54, 2007. 
 
Seale P, Bjork B, Yang W, Kajimura S, Kuang S, Scime A, Devarakonda S, Chin S, 
Conroe HM, Erdjument-Bromage H, et al.  Nature 454: 961-967, 2008. 
 
Secker-Walker LM, Mehta A, and Bain B.  Abnormalities of 3q21 and 3q26 in myeloid 
malignancy: a United Kingdom Cancer Cytogenic Group study.  Brit J Haemat 91: 490-
501, 1995. 
 
Seto Y, Nakajima H, Suto A, Shimoda K, Saito Y, Nakayama KI, and Iwamoto I.  
Enhanced Th2 cell-mediated allergic inflammation in Tyk2-deficient mice.  J Immunol 
170: 1077-1083, 2003. 
 
Shimoda K, Tsutsui H, Aoki K, Kato K, Matsuda T, Numata A, Takase K, Yamamoto T, 
Nukina H, Hoshino T, Asano Y, Gondo H, Okamura T, Okamura S, Nakayama K, 
Nakanishi K, Niho Y, and Harada M.  Partial impairment of interleukin-12 (IL-12) and IL-
18 signalign in Tyk2-deficient mice.  Blood 99: 2094-2099, 2002. 
 
Schleicher U, Mattner J, Bios M, Schindler H, Rollinghoff M, Karaghiosoff M, Muller M, 
Werner-Felmayer G, and Bogdan C.  Control of Leishmania major in the absence of Tyk2 
kinase.  Eur J Immunol 34: 519-529, 2004. 
 
Shuai K and Liu B.  Regulation of JAK-STAT signaling in the immune system.  Nat Rev 
Immunol 3: 900-911, 2003. 
 
Skulachev VP.  Fatty acid circuit as a physiological mechanism of uncoupling of oxidative 
phosphorylation.  FEBS Lett 294: 158-162, 1991. 
 
Snijder MB, et al.  Low subcutaneous thigh fat is a risk factor for unfavourable glucose 
and lipid levels, independently of high abdominal fat: The Health ABC Study.  
Diabetologia 48: 301-308, 2005. 
 
 68 
Stoiber D, Kovavic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, 
Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, and 
Sexl V.  J Clin Invest 114: 1650-1658, 2004. 
 
Tanko LB, Bagger YZ, Alexandersen P, et al.  Peripheral adiposity exhibits an independent 
dominant antiatherogenic effect in elderly women.  Circulation 107: 1626-1631, 2003.  
 
Timmons JA, Wennmalm K, Larsson O, Walden TB, Lassmann T, Petrovic N, Hamilton 
DL, Gimeno RE, Wahlestedt C, Baar K, Nedergaard J, Cannon B.  Myogenic gene 
expression signature establishes that brown and white adipocytes originate from distinct 
cell lineages.  Proc Natl Acad Sci USA 104: 4401-4406, 2007. 
 
Timmons JA and Pedersen BK.  The importance of brown adipose tissue.  N Engl J Med 
361: 415-416, 2009. 
 
Tiraby C, Tavernier G, Lefort C, Larruoy D, Bouillaud F, Ricquier D, and Langin D.  
Acquirement of Brown Fat Cell Features by Human White Adipocytes.  J Biol Chem 278: 
33370-33376, 2003. 
 
Tran TT, Yammoto Y, Gesta S, Kahn CR.  Beneficial effects of subcutaneous fat 
transplantation on metabolism.  Cell Metab 7: 410-420, 2008. 
 
Trayhurn P and Jennings G.  Evidence that fasting can induce a selective loss of 
uncoupling protein from brown adipose tissue mitochondria of mice.  Biosci Rep 6: 805-
810, 1986. 
 
Trayhurn P and Jennings G.  Nonshivering thermogenesis and the thermogenic capacity of 
brown fat in fasted and/or refed mice.  Am J Physiol 254: R11-R16, 1988. 
 
Tsuchiya T, Osanai T, Ishikawa A, Kato N, Watanabe Y, Ogino T.  Hibernomas show 
intense accumulation of FDG positron emission tomography.  J Comput Assist Tomogr 30: 
333-336, 2006. 
 
Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, 
Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, 
and Kahn CR.  New role of bone morphogenetic protein 7 in brown adipogenesis and 
energy expenditure.  Nature 454: 1000-1004, 2008. 
 
Tulp OL.  Effects of acute starvation on brown adipose tissue status in the rat.  Nutr Rep 
Int 28: 227-233, 1983. 
 
 69 
Uldry M, Yang W, St-Pierre J, Lin J, Seale P, and Spiegelman BM.  Complementary 
action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation.  
Cell Metab 3: 333-341, 2006. 
 
U.S. Department of Health and Human Services.  Overweight and obesity: a major public 
health issue.  Prevention Report 16, 2001. 
 
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al.  Cold-activated 
brown adipose tissue in healthy men.  N Engl J Med 360: 1500-1508, 2009. 
 
Vegiopoulos A, et al.  Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de 
Novo Recruitment of Brown Adipocytes.  Science 328: 1158-1161, 2010. 
 
Vernochet C, et al.  C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate 
repression of select visceral white adipose genes during induction of the brown phenotype 
in white adipocytes by peroxisome proliferator-activated receptor gamma agonists.  Mol 
Cell Biol 29: 4714-4728, 2009. 
 
Vijgen GHEJ, Bouvy ND, Teule GJJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD.  
Brown Adipose Tissue in Morbidly Obese Subjects.  PLoS One 6: e17247, 2011.  
 
Villarroya F, Iglesias R, and Giralt M.  PPARs in the Control of Uncoupling Proteins Gene 
expression. PPAR Res: 74364, 2007. 
 
Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine 
J, Savisto NJ, Enerback S, Nuutila P.  Functional brown adipose tissue in healthy adults.  N 
Engl J Med 260: 1518-1525, 2009. 
 
Wahrenberg H, Lonnqvist F, and Arner P.  Mechanisms underlying regional differences in 
lipolysis in human adipose tissue.  J Clin Invest 84: 458-467, 1989. 
 
Walden TB, Timmons JA, Keller P, Nedergaard J, Cannon B.  Distinct expression of 
muscle-specific microRNAs (myomirs) in brown adipocytes.  J Cell Physiol 218: 444-9, 
2009. 
 
Wang Y, Rimm EB, Stampfer MJ, Willett WC, and Hu FB.  Comparison of abdominal 
adiposity and overall obesity in predicting risk of type 2 diabetes among men.  Am J Clin 
Nutr 81: 555-563, 2005. 
 
Wang H, et al.  Liver X receptor alpha is a transcriptional repressor of the uncoupling 
protein 1 gene and the brown fat phenotype.  Mol Cell Biol 28: 2187-2200, 2008. 
 
 70 
Watford WT and O’Shea JJ.  Human tyk2 kinase deficiency: another primary 
immunodeficiency syndrome.  Immunity 25: 695-697, 2006. 
 
Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, 
Schindler C, Stark GR, Ihle JN, et al.  Complementation by the protein tyrosine kinase 
JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.  
Nature 366:166-170, 1993. 
 
Welborn JL, Lewis JP, Jenks H, Walling P.  Diagnostic and prognostic significance of 
t(1;3)(p36;q21) in the disorders of hematopoiesis.  Cancer Genet Cytogenet 28: 277-285, 
1987. 
 
Wilmore JH and Costill DL.  Training for Sport and Activity:  The Physiological Basis of 
the Conditioning Process.  Dubuque: William C. Brown, 1988. 
 
Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, 
Czech MP, and Corvera S.  Mitochondrial remodeling in adipose tissue associated with 
obesity and treatment with rosiglitazone.  J Clin Invest 114: 1281-1289, 2004. 
 
World Health Organization.  Fact Sheet: “Obesity and Overweight.”  Retrieved from 
www.who.int.  2008. 
 
Wu Z, Puigserver P, and Spiegelman BM.  Transcriptional activation of adipogenesis.  
Curr Opin Cell Biol 11: 689-694, 1999. 
 
Xue B, Coulter A, Rim JS, Koza RA, Kozak LP.  Transciprtional synergy and the 
regulation of Ucp1 during brown adipocyte induction in white fat depots.  Mol Cell Biol 
25: 8311-8322, 2005. 
 
Yamaoka K, Saharinen P, Pesu M, Holt VE, III, Silvennoinen O, and O’Shea JJ.  The 
Janus kinases (Jaks).  Genome Biol 5: 253, 2004. 
 
Yang X, Enerback S, and Smith U.  Reduced Expression of FOXC2 and Brown 
Adipogenic Genes in Human Subjects with Insulin Resistance.  Obes Res 11: 1182-1191, 
2003. 
 
Yen TT, Fuller RW, Hemrick-Leukkce SK, Dininger NB.  The antiobesity and metabolic 
activities of LY104119 in obese and normal mice.  Int J Obes 8: 69-87, 1984. 
 
Yoshida T, Sakane N, Wakabajashi Y, Umekawa T, Kondo M.  Anti-obesity and anti-
diabetic effects of CL 316,243, a highly specific beta3-adrenoceptor agonist, in yellow KK 
mice.  Life Sci 54: 491-498, 1994. 
 
 71 
Yoshida T, Sakane N, Wakabajashi Y, Umekawa T, Kondo M. Anti-obesity effect of CL 
316,243, a highly specific beta3-adrenoceptor agonist, in mice with monosodium-L-
glutamate-induced obesity.  Eur J Endocrinol 131: 97-102, 1994. 
 
Zhou Z, Toh SY, Chen Z, Guo K, Ng CP, Ponniah S, Lin S, Hong W, and Li P.  Cidea-
deficient mice have lean phenotype and are resistant to obesity.  Nat Genet 35: 49-56, 
2003. 
  
Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B, Nedergaard J, and 
Cinti S.  The presence of UCP1 demosntrates that metabolically active adipose tissue in the 
neck of adult humans truly represents brown adipose tissue.  FASEB J 23: 3113-3120, 
2009. 
 72 
 
 
 
 
VITA 
 
Samantha Miranda Umali was born in Norfolk, Virginia on April 4
th
, 1986.  In 
2008, Samantha received a Bachelor’s degree in Biology from the University of Virginia 
in Charlottesville, VA.  In 2009, she attended Virginia Commonwealth University School 
of Medicine in Richmond, VA to pursue a Certificate in Pre-Medical Basic Health 
Sciences, and she later pursued a Master’s degree in Biochemistry and Molecular Biology 
in 2010.  In August 2011, Samantha will spend her fourth year at VCU School of Medicine 
as a first-year medical student. 
 
